SlideShare a Scribd company logo
1 of 38
Download to read offline
Shamiul Bashar
1st
Batch
B. Pharm, VU
1
Pharmaceutical Excipients
Q. Define excipients. Why excipients are used in pharmaceutical preparation?
Excipient: Drug products contain both drug substance (commonly referred to as active
pharmaceutical ingredient or API) and excipients. An excipient is a pharmacologically inactive/ inert
substance formulated alongside the active pharmaceutical ingredient of a medication.
Excipients play a wide variety of functional roles in pharmaceutical dosage form, including-
1. Provide bulk to the formulation.
2. Aid in handling of “API” during manufacturing.
3. Ease of administration to the target patient population(s) by the intended route.
4. Improved dosing compliance (to give a particular shape and to improve palatability, elegance
of the formulation).
5. Facilitate drug absorption or solubility and other pharmacokinetic considerations.
6. Modulating solubility & bioavailability of APIs.
7. Consistency and control of drug bioavailability.
8. To enable bioavailability.
9. Improved API stability in dosage forms including protection from degradation/ denaturation.
10. To ensure a robust and reproducible physical product.
11. Helping active ingredients maintains preferred polymorphic forms or conformations,
12. Maintaining the pH and /or osmolarity of the liquid formulations,
13. Preventing aggregation or dissociation (e.g. of protein and polysaccharide actives).
14. Modulating immunogenic responses of active ingredients (e.g. adjuvants), and more.
N.B: Excipients, in certain cases, interacts with the active ingredient in the final formulated
dosage form or may provide a matrix that affects the critical quality attributes of the active ingredients
like stability and bioavailability.
Q. Classify excipients.
There are various types of excipients available in pharmaceutical formulation. They are,
1. Diluents. (Fillers/ bulking agents)
2. Binders.
3. Disintegrating agents.
4. Granulating agents.
5. Lubricants.
6. Glidants.
7. Preservatives.
8. Antioxidant.
9. Flavouring agents.
10. Sweeting agents.
11. Colouring agents.
12. Ointment base.
13. Solvent & Co-solvent.
14. Buffering Agents.
15. Chelating Agents.
16. Viscosity imparting Agents.
17. Surface Active Agents/ Surfactants.
18. Coating agents.
19. Sorbents.
20. Humectants.
Q. Write down the fundamental characteristic of pharmaceutical excipients.
Properties of an ideal excipient:
1. It should be feasible.
2. It should be nontoxic, nonirritant.
3. It should be nonvolatile.
4. It should be stable itself and not affected by temperature, light and hydrolysis.
5. It should be readily available and cheap.
6. It should be colourless, odourless and tasteless.
7. It should be soluble in water as well as oil and fat.
8. It should be compatible with the active ingredient in the preparation.
9. It should have no interaction with the API.
10. It should be pharmacologically inert in the formulation.
Pharmaceutical Excipients
Shamiul Bashar
1st
Batch
B. Pharm, VU
2
Pharmaceutical Excipients
Q. Write down the innovation in pharmaceutical excipients.
Innovation in pharmaceutical excipients: In general, there are three types of new excipients and
the development process of these varies significantly:
 Modified Excipients: Well known excipients with established quality standards can be
modified with regard to their impurity profile or their physical properties. The development
for modified excipients time is relatively short with a low R&D investment and a low
associated risk.
 Co-Processed Excipients: Two or more excipients are formulated without chemical changes
in order to achieve new performance characteristics which cannot be achieved by simple
physical mixing. The development of a co-processed excipient is more complex.
 Novel Excipients: It is used for the first time in a drug product or a new route of
administration. Novel excipient’s development is substantially similar to the non-clinical
development of a new active ingredient: A high R&D investment and a long development
time.
As a consequence, only very few manufacturers are willing to invest in the development of a
novel excipient.
Product development of new excipients has three main goals:
 To demonstrate the advantage over existing materials for the target application.
 To establish a reliable manufacturing process that leads to the desired product
characteristics.
 To demonstrate the appropriate stability of the new grade.
Q. Elucidate the different functional roles of excipients in different formulation.
The excipients, ingredients other than the active pharmaceutical ingredient, in a dosage form have
different functionalities, depending on how they are used in a formulation or the type of formulation
they are incorporated into. For a more in-depth discussion addressing dosage form development and
manufacturing concerns around excipient choice and use.
Certain excipients can have different functional roles in different formulation types, e.g. lactose;
widely used as:
• A diluent, filler or bulking agent in tablets and capsules
• A carrier for dry powder inhalation products (DPIs).
Furthermore, individual excipients can have different grades, types and sources depending on
those different functional roles.
For example, there are various grades of lactose commercially available that have different
physical properties, e.g. flow characteristics & particle size distributions. This permits selection of the
most suitable grade for a particular need.
• Wet Granulation: usually, finer grades of lactose are used so that the binder is more efficient
and this permits better mixing and granule quality.
• Direct Compression: in contrast here, spray dried lactose is used as it has good flow
properties and is more compressible.
• For dry powder inhalers: crash-crystallisation fine-milled lactose with a coarser fraction for
flow and a finer fraction to enhance API aerosolisation and delivery to the lungs.
Shamiul Bashar
1st
Batch
B. Pharm, VU
3
Pharmaceutical Excipients
Q. Define stability of pharmaceutical preparation and stabilizer. Classify it.
Stability: Stability of pharmaceutical product may be defined as the capability of a particular
formulation in a specific container closure to remain within the physical, chemical, microbiological,
therapeutic and toxicological specifications.
Stabilizers: The substances which are used to control these stabilities are known as stabilizers.
The most important stabilizers are,
1. Antioxidants and
2. Preservatives.
Diluents/ Fillers
Fillers typically also fill out the size of a tablet or capsule, making it practical to produce
and convenient for the consumer to use. e.g., Minimum tablet weight is typically ~50mg. Actual
API doses can be as low as ~20μg, e.g. for oral steroids.
When the quantity of a drug for an individual dose is very small then it is practically impossible to
compress then the inert substances which are added to increase the bulk for easy compression a
known as diluents. Diluent’s are filler used to make required bulk of tablet when the dosage itself is
inadequate to produce this bulk. Secondary reason is to provide better tablet properties such improved
cohesion, to permit use of direct compression manufacturing, or to promote flow.
Function of fillers:
 Bulking agent: Fillers add volume and/or mass to a drug substance, thereby
facilitating precise metering and handling thereof in the preparation of dosage forms .
Used in tablets and capsules.
 Compression aid: Deforms and/or fragments readily to facilitate robust bonding in tablet
compacts, e.g. microcrystalline cellulose.
 Good bulk powder flow diluents have a strong influence: Good flow of bulk powders is
very important in designing a robust commercial tablet product.
Typical features of fillers: An ideal diluent should have the following criteria-
1. They should typically be inert and non-toxic.
2. They should be preferably tasteless or pleasant tasting.
3. They must be compatible with the other components of the formulation.
4. They must be physically and chemically stable.
5. They must be non-hygroscopic.
6. They must be free from any unacceptable microbiologic load.
7. They must be commercially available is all acceptable grade.
8. They do not alter bioavailability of the drug.
9. They must be color compatible.
Examples: Plant cellulose and dibasic calcium phosphate are used popularly as fillers. A range
of vegetable fats and oils can be used in soft gelatin capsules. Other examples of fillers include:
lactose, sucrose, glucose, mannitol, sorbitol, calcium carbonate, calcium sulfate, magnesium stearate,
Microcrystalline cellulose (MCC), Powdered cellulose, Dextrates, Dextrin, Dextrose, Kaolin,
Maltodextrin, Starch, Sucrose
Favoured combinations: Lactose is an excellent choice of filler in many respects but can exhibit
poor flow characteristics, so is often combined with free-flowing microcrystalline cellulose in wet
granulation formulations.
Shamiul Bashar
1st
Batch
B. Pharm, VU
4
Pharmaceutical Excipients
Binders
Binders hold the ingredients in a tablet together. Binders ensure that tablets and granules can be
formed by increasing cohesive state of the drug powder, with required mechanical strength. In other
word according to WHO binders act as an adhesive to ‘bind together’ powders, granules and tablets to
result in the necessary mechanical strength:
• As a dry powder with other excipients in dry granulation (roller compaction, slugging) or as
an extra-granular excipient in a wet granulation tablet formulation.
• As a dry powder with other intra-granular excipients in wet granulation. When the granulating
fluid is added, the binder may dissolve partially or completely to then exhibit adhesive
binding properties in helping granules to form.
• Most commonly in wet granulation, the binder is added already dissolved in the granulating
fluid to enable a more effective and controllable granule formation.
• Water is the most common granulating fluid, very occasionally in a co-solvent system with,
e.g. ethanol.
Typical features of binders: A binder should be compatible with other products of formulation
and add sufficient cohesion to the powders.
Classification and examples: Binders are classified according to their application,
 Dry binders are added to the powder blend, either after a wet granulation step, or as part of a
direct powder compression (DC) formula. e.g., Pregelatinised starch, cross-linked PVP,
cellulose, methyl cellulose, and polyethylene glycol.
 Solution binders are dissolved in a solvent (for example water or alcohol can be used in wet
granulation processes). e.g., PVP, HPMC, gelatin, cellulose, cellulose derivatives, starch,
sucrose and polyethylene glycol.
 Soluble in water/ethanol mix: PVP
Acacia, Tragacanth, Gelatin, Sucrose, Starch paste are soluble in water and are not used in water
sensitive drugs, while Na-alginate, Methyl cellulose dissolved in alcohol and PVP, Methyl cellulose
drugs, while Na-alginate, Hydroxy Propyl cellulose dissolved both water and alcohol. In case of water
sensitive drugs first bender need to dissolve on alcohol and then other excipients and active
ingredients are mixed with it. Other example of binders include Alginic Acid, Sodium alginate,
Carboxymethyl cellulose sodium (CMC), Microcrystalline cellulose (MCC), Powdered cellulose,
Confectioner’s sugar, Dextrin, Dextrose, Ethylcellulose, Guar gum, Hydroxypropyl cellulose (HPC),
Hypromellose (HPMC), Lactose, Maltodextrin, Methylcellulose, Povidone, Zein.
Table: Some binders their concentration and required solvent are given below.
Binders Used concentration Required solvent
1. Acacia 2-5% H2O
2. Tragacanth 1-3% H2O
3. Sucrose 2-20% H2O
4. Gelatin 1-4% H2O
5. Starch past 1-4% H2O
6. Na-alginate 3-5% Alcohol
7. Methyl cellulose 1-4% Alcohol
8. Pyrrolidone 2-5% H2O and Alcohol
9. Ethyl celluese 0.2-0.5% H2O and Alcohol
Shamiul Bashar
1st
Batch
B. Pharm, VU
5
Pharmaceutical Excipients
Disintegrants
Disintegrants are substances or mixture of substances added to the drug formulations, which
facilitate dispersion or breakup (disintegration) of tablets and contents of capsules into smaller
particles for quick dissolution when it comes in contact with water in the GIT. They are mainly two
types-
a. Substances which hydrate and swell up in contact with water.
b. Substances which react with effervescent when they come in contact with moisture for
example combination of Na-CO3, citric acid and tartaric acid.
Ideal properties of disintigrants: Good hydration capacity , poor solubility , poor gel formation
capacity.
Mode of action:
• In many cases water uptake alone will cause disintegration, by rupturing the intra-particle
cohesive forces that hold the tablet together and resulting in subsequent disintegration.
• If swelling occurs simultaneously with water uptake, the channels for penetration are widened
by physical rupture and the penetration rate of water into the dosage form increased.
Examples: PVP, CMC, Sodium starch glycolate, Alginic Acid, Sodium alginate, Microcrystalline
cellulose (MCC), Croscarmellose sodium, Crospovidone, Guar gum, Polyacrilin Potassium, Sodium
Starch Glycolate, Veegum HV, bentonite 10% and cellulose derivatives Ac-Di-Sol(Na-CMC),
Alginate.
Q. Why are disintegrates added in two fractions for the formulation of tablet dosage form?
During manufacturing the tablets disintegrating agents are added in two steps-
a. Major par is incorporated to the powder before granulation.
b. Other part is mixed with the dried granulation along with lubricants before compression.
Disintegrates are added in a manner to serve two purposes-
a. The disintegrates added after granulation breaks the tablet apart into granules
b. The portion added before granulation convert granules into fine particles thus facilitating
tablet dissolution.
The disintegrating time depend on-
1. Quality of diluent, binder, lubricant
2. Hardness of tablet
3. Size of granules
4. And finally on coating.
Super disintegrates: These disintegrates which swells up to 10 to fold within 30 seconds when
they water. Significant improvement in disintegrant performance was achieved with the introduction
of the first super disintegrant. For example-
Cross carmellose-cross linked cellulose
Cross providone- cross linked providone
Sodium starch glycolate-cross linked starch.
Evaluation of CO2 on effervescent tablet is one of the ways of disintegration.
Shamiul Bashar
1st
Batch
B. Pharm, VU
6
Pharmaceutical Excipients
Granulating Agents
Granulating agents are the substances which are added to powders during granulating process to
convert fine powders into granules. Insufficient quantity of granulating agent may lead to poor
adhesion, soft tablets and capping, where as excessive quantity may lead to hard tablets into grater
disintegration time.
Example: Commonly used granulating agents are- water, mucillages of acacia, tragacanth,
Copolyvidone, sucrose and starch. Liquid glucose syrup and alcohol in various dilutions. Alcohols are
used for water sensitive drug.
Antiadherents, Lubricants & Glidants
Antiadherents: Antiaderents or anti-sticking agents prevent adhesion of the tablet surface to the
die walls and the punches and as a consequence counter the picking or sticking of tablet.
Examples of Antiadherents: Water insoluble lubricants such as magnesium stearate can be
used as antiadherents , as can talc and starch.
Lubricants: Lubricants prevent ingredients from clumping together and from sticking to the tablet
punches or capsule filling machine. Lubricants also ensure that tablet formation and ejection can
occur with low friction between the solid and die wall.
Types:
1. Hydrophilic- Generally poor lubricants, no glidant or anti-adherent properties.
2. Hydrophobic- Most widely used lubricants in use today are of the hydrophobic category.
Hydrophobic lubricants are generally good lubricants and are usually effective at relatively
low concentrations. Many also have both anti- adherent and glidant properties. For these
reasons, hydrophobic lubricants are used much more frequently than hydrophilic compounds.
Examples include magnesium stearate.
Roles of lubricants:
1. True Lubricant Role:
• To decrease friction at the interface between a tablet’s surface and the die wall during
ejection and reduce wear on punches & dies.
2. Anti-adherent Role:
• Prevent sticking to punch faces or in the case of encapsulation, lubricants
• Prevent sticking to machine dosators, tamping pins, etc.
3. Glidant Role:
• Enhance product flow by reducing interparticulate friction
Examples of lubricants: Polyethylene glycol, Stearic acid, Magnesium stearate, Calcium stearate,
Glyceryl monostearate, Isopropyl Myristate, Polyvinyl Alcohol, Sodium Stearyl Fumarate, Talc
Glidants: A substance (as colloidal silica) that enhances the flow of a granular mixture by reducing
inter-particle friction and that is used in the pharmaceutical production of tablets and capsule.
Functions of glidants: Glidants are used to promote powder flow by reducing interparticle friction
and cohesion. These are used in combination with lubricants as they have no ability to reduce die wall
friction.
Examples of Glidants: Fumed silica, Colloidal silicon dioxide, talc, syloid, aerosil and magnesium
carbonate.
Shamiul Bashar
1st
Batch
B. Pharm, VU
7
Pharmaceutical Excipients
Table: Different between glidant and lubricant
Glidant Lubricant
1. It improves the flow ability of the powder. 1. It ensures tablet formulation and ejection
with low fraction.
2. The glidant is often added to a granulation
before tableting.
2. Lubricant gives action after tableting.
3. They adhere particle surface of the other
ingredients and improve flow.
3. They adhere to the die wall.
4. They reduce the interparticulate friction. 4. Reduce friction between solid and die
cavity.
5. Usually glidant are solid. 5. Lubricant may be liquid.
6. e.g. Silica, Magnesium carbonate, talc,
syloid, aerosil etc.
6. e.g. Stearic acid, Magnesium stearate,
Calcium stearate, polyethylene glycol etc.
Preservatives
Preservatives are substances that commonly added to various foods and pharmaceutical products to
prevent or inhibit the growth of microorganisms in the preparations in order to prolong their shelf life.
Some preservatives, either by concentration or activity, may only maintain the bacteria level in the
product at the time of manufacture and are referred to as bacteriostatic preservatives.
Ideal properties of preservatives: In concept, the preservative system protects the product
against microbial proliferation but does not compromise product performance. In practice, this means
that it must:
1. Exert a wide spectrum of antimicrobial activity at low inclusion levels.
2. Maintain activity throughout product manufacture, shelf life and usage.
3. Not compromise the quality or performance of product, pack or delivery system.
4. Not adversely affect patient safety or tolerance of the product.
5. It should be effective against a wide range of microorganisms such as bacteria, mold and
fungi etc at room temperature.
6. It should be chemically compatible with other ingredients of the formulation.
7. It should be nontoxic and non-sensitizing.
8. It should be soluble in aqueous phase when used in emulsions.
9. If the system is biphasic, the partition-coefficient should be in favor of the aqueous phase.
10. It should be effective at low concentration.
11. It should be nontoxic, nonirritant.
12. It should be odourless, tasteless, and should not impart colour in the formulation.
13. It should be stable and effective over a wide range of pH.
14. It should be neutral and should not react chemically with other constituent.
15. It should be of low volatility to ensure that loss does not occur during storage.
16. It should be thermostable
17. It should preserve the preparations and remain stable for the shelf life of the product.
Examples: Methylparaen, Ethyl parabens, Propylparaben, Butylparaben, Benzoic acid and its salts,
Sorbic acid , Potassium Sorbate. Alcohol, Benzalkonium chloride, Boric acid, Butylated
Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Phenol, Phenethyl Alcohol, , Propylene
Glycol.
Shamiul Bashar
1st
Batch
B. Pharm, VU
8
Pharmaceutical Excipients
Q. Define combine preservative. Why more than one preservative are used in
pharmaceutical formulation.
Combine preservatives: The use of two or more preservative collectively known as combine
preservative.
No single preservative possesses all the ideal properties. Sometime a single preservative in not
enough or not have the ability to kill or inhibit the growth of microorganism. Therefore it becomes
necessary to use a combination of preservatives to prevent the growth of microorganisms. Then two
or more preservatives are used to increase their preservatives action. In combine preservatives, have a
broad spectrum of microbial qualities.
e.g., 0.1- 0.2% methyl paraben and propyl paraben which are oil and water soluble respectively
used due to their synergist effect in combined form.
Q. How you will evaluate preservatives? Problems of selection of preservatives.
Evaluation of preservatives:
1. To assess the number of viable number or microbes in the final product as in function of
time.
2. To assess the quantities of preservatives compound at specific interval of time.
Problems of selection of preservatives:
1. The problem of selection of preservatives for emulsion systems is unique.
2. It is desirable to have a compound which distributes to a large extent in the aqueous
phase. At the same time the preservatives compound must have a tendency to get
concentrated in the lipids of microbial cell in preference to remaining in the aqueous
phase.
Q. Write on about benzoic acid & benzoate, parahydroxybenzoates, phenyl mercuric
nitrate & other salt, phenol, dichlorophen, formaldehyde.
Benzoic acid and benzoates
1. Simple aromatic acid.
2. Use as a preservative for food, drug, cosmetics etc.
3. Concentration 0.1%.
Salicylic acid and salicylates
Use as sodium salicylate for enfant of 1 part to 1000.
Parahydroxybenzoates
1. Use for the preservation of food and drug.
2. Various ester of p-hydroxy benzoic acid having methyl, ethyl propyl and butyl radicals
are marketed by different forms under names such as Nipase ceries paraben etc.
3. Concentration 0.005-0.05%
4. Powerful preservative.
5. The esters are considered to be 2-3 times effective as benzoic acid.
6. The different ester may have different action against different classes of microbes. For
instance, a methyl ester is considered to be more effective against mould. Propyl ester is
so against yeasts.
Phenyl mercuric nitrate & other salt
1. Low concentration as 1 in 1,00,000.
2. Use for cosmetic.
3. It is recognized preservatives of pharmaceutical product for parental use.
Shamiul Bashar
1st
Batch
B. Pharm, VU
9
Pharmaceutical Excipients
Phenol
1. Classical germicide.
2. Use in lotion and other preparation for internal use.
3. Used in particular products packed as multiple doses in concentration of 0.5%
Dichlorophen
1. Fungicide and bactericide.
2. Use for preservation of natural fiber like cotton and wool.
3. Use as an ingredient for hair tonic and athletes.
4. It is rather tonic and not use in pharmaceutical preparation as preservatives.
Formaldehyde
1. Good preservatives for different kind of material.
2. It is not use in pharmaceutical preparation as preservatives.
3. Is has strong pungent and irritant properties.
Antioxidant
Antioxidant: An antioxidant is a substance which is added to pharmaceutical formulation to prevent
the oxidative degradation of the drug in the presence of oxygen or peroxides. They act by blocking an
oxidative chain reaction. The antioxidants have great affinity for oxygen and when they are added to
formulation they compete for its affording protection to other oxygen sensitive drug.
Function of anti-oxidant: Used to control oxidation of-
 API
 Preservative, e.g. potassium sorbate
 Vehicle, e.g. oils or fats susceptible to β-oxidation (rancidification)
 Colourants (ageing discolouration)
Some antioxidants are:
1. Quinol group:
 Hydroquinone
 Tocopherols
 Hydroxychromans
2. Catechol group:
 Catechol
 Pyrogallol
 Gallic Acid
 Ethyl Gallate
3. Nitrogen containing Substance:
 Alkanolamine
 Diphenylamines
 Casein
 Edestine
4. Sulphur containg Substance:
 Cysteine Hydrochloride
5. Monohydric Phenol:
 Thymol
Concentration of antioxidant in formulation: 0.001 – 0.1%
Classification of antioxidant:
1. On the basis of the function antioxidants are 2 types. They are,
a. Primary antioxidant/ true antioxidant.
b. Synergist.
a. Primary antioxidant: Primary antioxidants act by interfering with the propagation step
of autoxidaton process.
e.g., Tocopherol (Vitamin E), Gallic acid, Butylated hydroxyl anisol (BHA), Butylated
hydroxyl tolune (BHT) and nordihydroguaiaretic acid (NDGA).
Shamiul Bashar
1st
Batch
B. Pharm, VU
10
Pharmaceutical Excipients
b. Synergist: The synergist class of antioxidants has little inherent antioxidal properties.
However, when used in conjugation with a primary antioxidant they have the ability
greatly to enhance antioxidant efficiency. e.g.,
1. Water Soluble:
 Citric Acid
 Tartaric Acid
 Phosphoric Acid
 Ascorbic Acid (having antioxidant
property)
2. Oil Soluble:
 Ascorbyl Palmitate
 Mono-isopropyl
Citrate
 Palmityl Phosphate
 Mono-stearyl Citrate
2. On the basis of the source antioxidants are 2 types. They are,
a. Natural antioxidants.
b. Synergist antioxidant.
a. Natural antioxidant: These exist and available in nature.
e.g., Tocopherol (Vitamin E), Sesamol, Guaiac resin, Mehionine.
b. Synthetic antioxidant: These are isolated by synthesis by an artificial mean.
i.e Butylated hydroxyl anisol (BHA), Butylated hydroxyl tolune (BHT), Tertiary butyl
hydroquinone.
3. On the basis of solubility antioxidants are 2 types. They are,
a. Water soluble antioxidant.
b. Oil soluble antioxidant.
a. Water soluble antioxidant: The main classes of water soluble antioxidants are sulfurous
acid salt, ascorbic acid isomers and thhiol derivatives.
Compound Drug for which suitable
Sodium Metabisulfite
1. Steroids.
2. Antibiotics.
3. Adrenergic.
4. Procainaonid.
5. Morphine.
b. Oil soluble antioxidant: The oil soluble antioxidants are often needed for the protection
of fatly food and osmotic.
Compound Material for which suitable
BHA and BHT Fatty formulation.
Properties of Antioxidants:
1. An ideal antioxidant should be stable.
2. Effective at a low, nontoxic concentration.
3. It should not posses objectionable color, odor and taste.
4. It should be nontoxic, nonirritant and form no harmful products.
5. It should be thermostable.
6. It should be readily soluble or dispersible in the medium.
7. Soluble at the required concentration.
8. It should be compatible with formulation ingredients and packaging material.
9. Stable and effective under normal conditions of use, over a wide pH and temperature range.
10. Compatible with a wide variety of drugs and pharmaceutical excipients.
11. It should be neutral and should not react chemically with other constituents present.
12. Colorless in both the original and oxidized form.
13. Nontoxic both internally and externally at the required concentration.
14. Reasonable cost.
15. Unreactive (does not adsorb, penetrate, or interact) with containers or closures.
Shamiul Bashar
1st
Batch
B. Pharm, VU
11
Pharmaceutical Excipients
Mode of action: Anti-oxidants act by-
1. By acting as a reducing agent.
2. By acting as free radical inhibitor to block the oxidative chain reaction.
3. By acting as synergist increasing the efficiency of antioxidant.
4. By acting a chelating agent such as EDTA salt. This salt complex with metal ion which
catalyze the oxidative reaction.
Q. Define oxidation, auto-oxidation, and pre-oxidants.
Oxidation: Oxidation is defined as loss of electrons or addition of oxygen.
Auto-oxidation: It is a reaction with oxygen of air which occurs spontaneously without other
factors.
Pre-oxidants: These are substances catalyze oxidation process e.g., metals, some impurities.
Q. Write down the chemical groups which undergo oxidation.
Chemical groups which undergo oxidation:
1. Phenolic compounds: Phenylephrine.
2. Catechol derivatives: Adrenaline and noradrenaline.
3. Some antibiotics: Tetracyclines.
4. Oils (fixed and volatile).
5. Vitamins (lipid and water soluble).
Q. How to evaluate oxidation in pharmaceutical agent form?
By monitoring the following objective we can identify oxidation.
1. Change of color, odor, and viscosity of screening/ pharmaceutical agents.
2. For fixed and volatile oils: change of color, taste, odor, and viscosity
Q. How you can protect pharmaceutical from oxidation?
Protection of drugs from oxidation:
1. Addition of Antioxidants: Vitamin E, vitamin C and inorganic sulfur compounds,
thiosulfate and polysulfide.
2. Addition of chemicals which form complexes with metals e.g., EDTA, Benzalkonium
chloride
3. Protection from light:
a. Using of dark container.
b. Storage in dark places.
c. Packaging with substances which absorbed light e.g., Oxybenzene.
4. Choice of suitable pharmaceutical dosage forms which reduce the possibility of oxidation
process (solid dosage forms are better than solutions).
5. Maintenance of pH by using buffer solution.
6. Choice of suitable solvent (rather than water).
7. Storage in low temperature.
8. Protection from air by:
a. Using good closed containers.
b. Replacement of oxygen by nitrogen.
Shamiul Bashar
1st
Batch
B. Pharm, VU
12
Pharmaceutical Excipients
Q. Mention commonly used drugs sensitive to oxidation.
Drugs that are sensitive to oxidation are,
1. Ascorbic acid (Vitamin C)
2. Chlorpromazine.
3. Cyanocobalamine (Vitamin B12)
4. Gentamicin.
5. Heparin.
6. Hydrocortisone.
7. Resorcinol.
8. Riboflavin (Vitamin E)
9. Streptomycine.
10. Methyldopa.
11. Morphine.
12. Penicillin.
13. Tetracycline.
14. Thiamine (Vitamin B1)
15. Vitamin A,D and E
16. Paracetamol
Sweetening agents
Sweetening agents are employed in liquid formulations designed for oral administration
specifically to increase the palatability of the therapeutic agent.
Example: Sucrouse, Lactose, Saccarine, Aspertame, Sorbitol, Mannitol etc.
Uses of sweetening agent:
 The main sweetening agents employed in oral preparations are sucrose, liquid glucose,
glycerol, sorbitol, saccharin sodium and aspartame. Aspartame is an artificial sweetening
agent. The use of artificial sweetening agents in formulations is increasing.
 In anthelmintic and multivitamin tablets sweeting agents are used.
 The use of sugars in oral formulations for children and patients with diabetes mellitus is to be
avoided.
Why mannitol is extensively used in chewable tablets:
Chewable tablets are intended to be chewed in the mouth prior to swallowing and are not intended
to be swallowed intact.
The use of sweeteners is primarily limited to the chewable tablets to exclude or limit the use of
sugar in the tablet. Sucrose causes hyperglycaemia. So we have to exclude it in the chewable tablet.
Saccharine can use in place of sucrose, but it has the disadvantage that it has a bitter after taste and
has been reported to be carcinogenic. Aspartame can be used in place of saccharine, but the primary
disadvantage of aspartame is its lack of stability in the presence of moisture. For the above reason
mannitol is used extensively in the chewable tablet because-
a. Mannitol is reportedly about 72% as sweet as sucrose.
b. It does not have bitter after taste.
c. It has the stability in the presence of moisture.
d. It does not produce hyperglycaemia.
Flavoring Agents
Flavouring agents are the substances which are used to impart pleasant, smell to the preparation
and to mask specific type of taste of the preparation, thus make them more palatable and improve
patient acceptance. The four basic taste sensations are salty, sweet, bitter and sour. It has been
proposed that certain flavours should be used to mask these specific taste sensations.
Example: Clove oil, citric and syrup, glycerin, rose oil, orange oil, raspberry flavor, vanilla flavor
etc.
Shamiul Bashar
1st
Batch
B. Pharm, VU
13
Pharmaceutical Excipients
Classification flavouring agents:
1. Natural flavouring agent: The flavouring agents obtained from natural sources include pine-
apple, banana, cardamom, ginger, cinnamom, peppermint and volatile oils obtained from
anise, caraway clove, dill, lemon oil, orange, rose, jasmine, lavender etc. Malt extract.
glycyrrhizin extract, coffee, vanilla, chocolate and tolu balsam are also used as flavouring
agents. Menthol, mannitol, chloroform spirit and chloroform water are widely used as
flavouring agents in liquid formulations.
2. Synthetic colouring agent: Synthetic chemical like certain alcohol, aldehydes, esters, fatly
acids, ketones and lactones are used as flavouring agents. More recent butterscotch, ‘tutti-
frutti’ flavor are used.
Q. Why synthetic flavouring agents are better than natural flavouring agents.
Most of the flavours used in pharmaceutical preparations are obtained from natural sources but
now a days they are being replaced by synthetic flavours. This is due to,
1. They are constant in composition.
2. They are readily available.
3. They are comparatively cheap.
4. They are more stable.
5. Their incompatibilities are more predictable.
Coloring and Opacifying Agent
Coloring agents are pharmaceutical ingredients that impart the preferred color to the formulation.
The function of these ingredients is to enhance the product quality. They provide-
1. Product identification.
2. Protect the core from light and moisture.
3. They increase the solid concentration with any impact on viscosity thus reducing the drying
time.
They are either soluble or form fine suspension in the solvent system. For uniform distribution the
particle size must be < 10 microns. If a very light shade is desired a concentration is less than 0.01%.
On the other hand if dark color is required concentration is more than 2%.
Example:
White: Titanium dioxide
Blue : Brilliant blue ,Indigo carmine
Red : Amaranth Carmine
Yellow: saffron
Green
Brown: caramel
Dyes are soluble forms of a particular color. They go into solution and can result in very deep, vibrant
colors and therefore used in liquid products. The most common colorants used are FD&C or D&C
certified, these are either dyes or lakes of dyes.
FDC red-2 Amaranth
FDC green -3 Green
FDC green -4 Erithrosine
FDC yellow-5&6 Tartrasine
FDC blue-1 Brilliant blue
FDC blue-2 Indigo
Lakes are dyes that undergo a processing step that adheres them onto insoluble substrates. Since lake
contain less colorant so required in larger concentration in solution. Lakes are used in chewable
products and coating solutions for tablets. e.g., aluminum or calcium salts, iron oxide, anthrocyanins,
caramel, carotenoids, chlorophyll, indigo, flavones, turmeric acid and carminic acid.
Opacifiers are used to give more pastel color and increase film coverage. These can provide white
coat or mask the color of the tablet core. These are mostly inorganic material. The substances
employed are- Titanium dioxide (Most Common), Talc, Aluminum silicate, Magnesium carbonate,
Calcium sulfate, Aluminum hydroxide
Shamiul Bashar
1st
Batch
B. Pharm, VU
14
Pharmaceutical Excipients
Ointment Bases
Q. Define ointment bases and mention its ideal properties.
Ointment Bases: The ointment base is that substance or part of an ointment which serves as a
carrier or vehicle for the medicament.
Properties of an ideal ointment base:
1. It should be inert.
2. It should be stable.
3. It should be smooth.
4. It should be compatible with the skin.
5. It should be non-toxic and non-irritating.
6. It should be nonvolatile.
7. It should have low melting point.
8. It should release the incorporated medicament readily.
Since there is no single ointment base available which possesses all these qualities, therefore it
becomes necessary to use more than one ointment base in the preparation of ointments.
Q. Classify ointment base.
The ointment bases are classified as follows:
1. Oleaginous bases
2. Absorption bases
3. Emulsion bases
4. Water soluble bases.
Q. Describe oleaginous base with its disadvantage
Oleaginous Bases: These bases consist of water insoluble hydrophobic oils and fats. The most
important are the hydrocarbons. i.e. mineral oil, petrolatums and paraffins. The animal fat includes
lard. The combination of these materials can produce a product having desired melting point and
viscosity. The oleaginous bases are decreasing in favour due to the reasons described
1. They are greasy.
2. They are difficult to remove both from skin and clothings.
3. The release of medicament is not certain.
4. If some animal fat is included it may get rancid.
5. Fatty mixture bases prevent drainage on oozing areas and also prevent evaporation of
cutaneous secretions including perspiration. The water retention increases the heat in the
particular areas.
Q. Briefly describe hydrocarbon bases.
Hydrocarbon Bases
1. Petrolatum (Soft Paraffin): It is a purified mixture of semisolid hydrocarbons obtained from
petroleum. There are two varieties of soft paraffin, one is yellow soft paraffin and the other is white
soft paraffin. Yellow soft paraffin is a pale yellow to yellow translucent soft mass, free or almost free
from odour and taste. It has a melting point of 38°C to 56°C.
White soft paraffin is obtained by bleaching yellow soft paraffin. It is a white translucent tasteless
mass and is odourless when rubbed on the skin. It has a melting point of 38°C to 56°C. White soft
paraffin is used when the medicament is while or colourless.
Both yellow and white soft paraffins are used and have no noticeable action on the skin and are
not absorbed. Thus they are suitable for epidermal type of preparations. Because of hydrophobic
nature, aqueous liquids cannot be mixed with it but sometimes wool fat and waxes are included to
incorporate aqueous liquids in it.
Shamiul Bashar
1st
Batch
B. Pharm, VU
15
Pharmaceutical Excipients
2. Hard Paraffin: It is a purified mixture of solid hydrocarbons obtained by distillation from
petroleum or shale oil. It is a colourless or white translucent, odourless, tasteless mass and is used to
harden or stiffen the ointment bases.
3. Liquid Paraffin: It is also known as liquid petrolatum or white mineral oil. It consists of a
mixture of liquid hydrocarbons and may be obtained from petroleum by distillation. Liquid paraffin
varies in composition according to the source of the petroleum. It is a colourless, transparent, tasteless
and odourless oily liquid. It is insoluble in water and alcohol but soluble in ether and chloroform.
It is used along with hard paraffin and soft paraffin to get a desired consistency of the ointment. It
is also used to levigate the substances insoluble in it.
Q. Briefly describe absorption base. Give its advantage and disadvantage.
Absorption Bases: The term absorption is used to denote the hydrophilic characters of the base.
These are generally anhydrous bases which can absorb a large amount of water but still retain their
ointment like consistency. The following are some of the absorption bases used.
1. Wool Fat:
a. It is also known as anhydrous lanolin.
b. It is the purified anhydrous fat like substance obtained from the wool of sheep.
c. It is practically insoluble in water but can absorb about 50% of its weight of water.
d. Due to its sticky nature it is not used alone but is used along with other bases in the
preparation of a number of ointments.
2. Hydrous Wool Fat:
a. It is also known as lanolin.
b. It is the purified fat like substance obtained from wool of sheep.
c. It is a yellowish white ointment like mass with characteristic odour.
d. It is insoluble in water but soluble in ether and chloroform.
3. Wool Alcohol:
a. It is obtained from wool fat by treating it with alkali and separating the fraction
containing cholesterol and other alcohols.
b. It contains not less than 30% of cholesterol.
c. It is used as an emulsifying agent for the preparation of water in oil emulsions and is used
to absorb water in ointment bases.
d. It is also used to improve the texture, stability and emollient properties of oil in water
emulsions.
4. Bees Wax:
a. It is purified wax obtained from the honeycomb of bees.
b. It is of two types: (a) yellow bees wax and (b) white bees wax obtained by bleaching and
purifying the yellow bees wax.
c. Bees wax is used as a stiffening agent in pastes, ointments and other preparations.
5. Cholesterol:
a. It is widely distributed in animal organisms.
b. Wool fat is also used as a source of cholesterol. It is used to increase the incorporation of
aqueous substances in oils and fats.
Advantages of Absorption Bases
1. They are compatible with majority of medicaments.
2. They are relatively heat stable.
3. These bases may be used in their anhydrous form or in emulsified form.
4. They can absorb a large quantity of water or aqueous substances.
5. They can be more easily removed from the skin in compared to the oily bases.
Disadvantages of Absorption Bases
1. These bases possess the undesirable property of greasiness.
Shamiul Bashar
1st
Batch
B. Pharm, VU
16
Pharmaceutical Excipients
Q. Write a short note on i. Emulsion and ii. Water absorption base.
i. Emulsion Bases: Emulsion bases are semi solid emulsions having cream like consistency.
These are of two types: oil in water or water in oil emulsions. Some additional amount of water can be
incorporated in both the types and still retain soft cream like consistency. The oil in water type
emulsion bases are more popular because they can be easily removed from the skin or clothings by
washing with water. The water in oil emulsion bases are greasy and sticky, therefore they are difficult
to remove from the body and clothings. Examples of emulsion bases include hydrophilic ointment,
rose water ointment and vanishing creams.
ii. Water Soluble Bases: Water soluble bases contain only the water soluble ingredients and not
the fats or other greasy substances that is why sometimes they are known as greaseless bases. They
differ from emulsion bases that the latter contain water soluble and water insoluble components. Since
these bases do not contain ally fats or oils, they can be easily washed with water from the skin and
clothings.
Certain other substances which are used as water soluble bases include tragacanth, gelatin, pectin,
silica gel, sodium alginate, cellulose derivatives, magnesiutn-aluminium silicate and bentonite. In the
true sense these substances are not water soluble but they swell up with the absorption of water.
Q. Define carbowaxes wits its ideal properties.
Carbowaxes: Water soluble bases consist of water soluble ingredients such as polyethylene
glycol polymers which are popularly known as carbowaxes.
Ideal properties of Carbowaxes:
1. Carbowaxes are water soluble.
2. They are non-volatile.
3. They are inert substances.
4. They do not hydrolyse and do not support the bacterial or mold growth.
5. The release of medicament is rapid.
6. A blend of different carbowaxes is used to get an ointment of desired consistency.
Q. Mention the factor governing selection of an ideal ointment base.
Factors Governing Selection of an Ideal Ointment Base: The factors which may help in the
selection of an ideal ointment base are discussed below:
1. Dermatological factors.
2. Pharmaceutical factors.
1. Dermatological Factors
a. Absorption and Penetration: The word 'absorption' means actual entry into the blood
stream, i.e. systemic absorption whereas 'penetration' means transference through the skin, i.e,
cutaneous penetration.
Various experiments have been conducted by a number of scientists to study the problems of
absorption and penetration which may be summarized as follows:
i. Only the ointment base penetrates deep into the tissues of the skin.
ii. It is mainly medicament which is absorbed into the blood stream.
iii. Paraffins do not readily penetrate the skin whereas animal and vegetable fats and oils
normally penetrate the skin. Animal fats, e.g. lard and wool fat when combined with
water, penetrates the skin.
iv. Substances which are soluble both in oil and water are most readily absorbed.
v. Water soluble substances are more readily absorbed from water soluble bases.
vi. O/W emulsion bases release the medicament more readily than greasy bases or W/O
emulsion bases.
Shamiul Bashar
1st
Batch
B. Pharm, VU
17
Pharmaceutical Excipients
b. Effect on Skin Function: Greasy bases interfere with normal skin functions, i.e. heat
radiation and sweat. 'They are irritant to the skin. O/W emulsion bases and other water miscible bases
produce a cooling effect rather than heating effect and mix readily with skin secretions.
c. Miscibility with Skin Secretions and Serum: Skin secretions are more readily miscible with
emulsion bases than with greasy bases. Due to this miscibility the drug is more rapidly and completely
released to the skin hence lesser proportion of the medicament rs required when such bases are used.
O/W emulsion bases are more readily miscible with serum from broken skin therefore they are
particularly useful in weeping eczema.
d. Compatibility with Skin Secretions: The bases used should be compatible with skin
secretions and should have a pH about 5.5 because the average pH of the skin secretions is around 5.5.
Generally neutral ointment bases are preferred.
e. Freedom from Irritant Effect: Ointment bases used should be free from irritant effect on the
skin. All bases used should be of high standard of purity and bases used specially for eye ointments
should be non-irritating and free from foreign particles.
f. Emollient Properties: Dryness and brittleness of the skin causes discomfort to the skin
therefore the bases used should possess emollient properties that they should be able to keep the skin
moist. For this purpose water and humectants such as glycerin and propylene glycol are used.
Ointments containing wool fat, lard and liquid paraffin also act as emollients by preventing rapid loss
of moisture from the skin.
g. Ease of Application and Removal: The ointment bases used should be easily applicable as
well as easily removable from the skin. Stiff and sticky ointments are not suitable as they may cause
damage to the newly formed tissues of the skin. Therefore emulsion bases are more preferred as they
are softer and spread more readily over the area to which they are applied. They can be easily
removed by simply washing with water.
2. Pharmaceutical Factors
a. Stability: Fats and oils obtained from animal and vegetable sources are liable to undergo
oxidation unless they are suitably preserved. Lard, an animal fat used to be a common ingredient of
ointment) but it is rarely used now a days because it easily gets rancid. Soft paraffin, simple ointment
and paraffin ointment are inert and stable. Liquid paraffin is also stable but on prolonged storage it
gets oxidized therefore an antioxidant like tocopherol may be incorporated. Emulsions prepared with
wool fat are liable to surface discolouration. O/W type emulsion bases provide a good medium for
growth of microorganisms, therefore must be suitably preserved.
b. Solvent Properties: Most of the medicaments used in the preparation of ointments are
insoluble in the ointment bases therefore they are finely powdered and distributed uniformly
throughout the base. Phenol, if dispersed in finely powdered state may cause blisters therefore it must
be dispersed in a suitable base which should keep the phenol in solution form. Hence a base
consisting of a mixture of hard paraffin, soft paraffins, bees wax and lard is used for this purpose.
Similarly in the case of compound mercury ointment, olive oil is used to keep the camphor in solution
form.
c. Emulsifying Properties: Hydrocarbon bases can absorb only a small amount of aqueous
substances whereas some animal fats can absorb an appreciable amount of water, e.g. wool fat can
take up about 50% of water, and when mixed with other fats can take up several times its own weight
of aqueous or hydroalcoholic liquids. Hence wool fat is included in the base for eye ointments.
Emulsifying ointment, cetrimide emulsifying ointment and cetomacrogol emulsifying ointment
are capable of absorbing considerable amount of water, forming oil in water creams.
d. Consistency: The ointments produced should be of suitable consistency. They should neither
be too hard nor too soft. They should withstand the climatic conditions. Thus in summer they should
not become too soft and in winter not too hard to be difficult to remove from the container and spread
on the skin.
Shamiul Bashar
1st
Batch
B. Pharm, VU
18
Pharmaceutical Excipients
Coating Agent
Coating is a process by which an essentially dry, outer layer of coating material is applied to the
surface of a dosage form and agents which are used in this coating process is called coating agents.
Similar to taste masking technology, the first coatings were solutions of sucrose (12–20%). Once
polymers were discovered and understood, they were applied in low concentrations (1–3%) using
organic solvents. Current technology uses polymers manufactured as latex or pseudo-latex dispersions
to avoid the use of organic solvents. Depending on the application, aesthetic or functional coating, the
use levels can range from 2 to 20% of the weight of the material being coated.
Types: Three types of coating agents are used pharmaceutically,
1. Film coating.
2. Sugar coating.
3. Compression coating.
Function of coating agents:
1. To improve appearance: often where the core tablet is of poor colour or shows mottling.
2. Protection from environmental conditions: Some of the ingredients may not be stable in the
presence of moisture, light, oxygen etc. The product stability can be improved by coating.
3. Taste masking: Mask the bitter or unpleasant taste.
4. Odour masking: Mask the unpleasant odour of active ingredients like vitamins, antibiotics
etc.
5. Change in appearance: To impart colour for easy identification during manufacture,
dispensing, in use by patient and brand image building.
6. Ease of swallowing
Examples: Excipients, Carboxymethyl cellulose sodium (CMC), Carnauba Wax, Cellulose acetate,
phthalate (CAP), Ethylcellulose, Gelatin, Hydroxypropyl cellulose (HPC), Hypromellose (HPMC),
Maltodextrin, Methylcellulose, Starch, Sucrose, Zein.
Sorbents
Sorbents are materials that soak up oil from the water.
Types and examples of sorbents:
• Natural sorbents- peat moss, sawdust, feathers, and anything else natural that contains carbon.
• Synthetic sorbents- polyethylene and nylon etc..
Functions of sorbents: Sorbent are used for tablet/capsule moisture-proofing by limited fluid sorbing
(taking up of a liquid or a gas either by adsorption or by adsorption) in a dry state.
Solvents/Co-Solvents
Solvent: A solvent is a substance that can dissolve a solute (a chemically different liquid, solid or
gas) resulting in solution. A solvent is usually a liquid but it can also be solid or a gas. A solvent never
changes its state forming a solution.
Ideal characteristics of solvent:
1. It should either dissolve or disperse the polymer system.
2. It should easily disperse other coating solution component into the solvent system.
Shamiul Bashar
1st
Batch
B. Pharm, VU
19
Pharmaceutical Excipients
3. Small concentration of polymer (2-10%) should not result in an extremely viscous solution
system (>300cps) creating processing problem.
4. It should be colorless, tasteless, odorless, in-expensive, non-toxic, inert and non-flammable.
5. It should have rapid drying rate.
6. It should have no environmental impact.
Solvent classification: On the basis of the forces of interaction occurring in solvents, one may
broadly classify solvents as one of three types:
1. Polar solvents: Those made up of strong dipolar molecules having hydrogen bonding are
known as polar solvent. e.g., water or hydrogen peroxide.
2. Semi-polar solvents: Those also made up of strong dipolar molecules but that do not form
hydrogen bonds are known as semi-polar solvent. e.g., acetone or pentyl alcohol.
3. Non-polar solvents: Those made up of molecules having a small or no dipolar characters are
known as non-polar solvent. e.g., benzene, vegetable oil, or mineral oil.
Normally solvation of a solvent depends upon its classification. Generally polar solvent dissolves
polar compound best and non polar solvent dissolves non polar compound best.
Example and uses of solvent
• The first choice for a solvent is water in which a drug is freely soluble.
• Water –miscible solvent such as Chlordiazepoxide hydrochloride can be used to improve
solubility and stability.
• Oils are used as emulsion, intramuscular injections and liquid fill oral preparation.
• Aqueous methanol is widely used in HPLC and is the standard solvent in sample extraction.
• Other acceptable non-aqueous solvents are glycerol, propylene glycol, ethanol and are used
generally for a lipophilic drug.
Water is the solvent most widely used as a vehicle due to:
 Lack of toxicity, physiological compatibility, and good solubilising power (high dielectric
constant), but
 Likely to cause instability of hydrolytically unstable drugs
 Good vehicle for microbial growth
Co-solvent: Co-solvents are defined as water-miscible organic solvents that are used in liquid drug
formulations to increase the solubility of poorly water soluble substances or to enhance the chemical
stability of a drug.
Properties of co-solvent
• Co-solvent increases the solubility of a drug.
• An ideal co-solvent should possess values of dielectric constant between 25 and 80.
• The most widely used system that will cover this range is a water/ethanol blend.
• It should not cause toxicity or irritancy when administrated for oral or parental use
• Other co-solvents are sorbitol, glycerol, propylene glycol and syrup.
Application of co-solvent:
 Water-miscible co-solvents are used to:
 Enhance solubility, taste, anti-microbial effectiveness or stability
 Reduce dose volume (e.g. oral, injections)
 Or, conversely, optimise insolubility (if taste of API is an issue)
 Examples: propylene glycol, glycerol, ethanol, low molecular weight PEGs
 Water-immiscible co-solvents, e.g.
 Emulsions / microemulsions using fractionated coconut oils
Shamiul Bashar
1st
Batch
B. Pharm, VU
20
Pharmaceutical Excipients
Chelating agent
Chelating agents are molecules that are capable of forming complexes with the drug involving
more than one bond it’s a complex compound contains one or more ring in its structure .
Complexing agents also called “sequestrants” are substances which form chemical complexes
with metallic ions. Sequestrants are used to stabilize fats and oils which undergo rancidity and
reversion in the presence of the metals copper and iron. By chelating (sequestering) metals, oxidation
is slow or entirely prevented. Calcium-Dinatrium-EDTA E385 is the most used one.
e.g., ethylene diamine is bidentate and ethylene diamine tetraacetic acid is hexadentate.
Example and uses of chelating agent:
• EDTA: ethylene diamine tetraacetate is used for the estimation of metals ions.
• EDTAH4: ethylene diamin tetraacetic acid is used for softening water.
• Calcium Disodium Edetate: it is used in the treatment of heavy metal poisoning mostly
caused by lead.
• Disodium Edetate: it is used in hypercalcemic states. It is also useful in the treatment of
cardiac arrhythmias.
Buffering agent
These are materials which, when dissolved in solvent will enable the solution to resist any change
in pH should an acid or an alkali be added. The choice of suitable buffer depends on the pH and
buffering capacity required.
Change in the pH of preparation may occur during storage because of degradative reaction in the
product. Interaction of the product with container component and dissolution or loss of gases vapours.
So, buffers are used to maintain a required pH of the formulation in order to:
• Ensure physiological compatibility
• Maintaining/optimising chemical stability
• Maintaining/optimising anti-microbial effectiveness
• Optimise solubility (or insolubility if taste is an issue)
The principle buffer systems employed for parenteral preparation are acetate, citrate and phosphate.
Buffer system with concentration:
Name of buffer System Concentration
Acetate CH3COOH + CH3COONa 1-2%
Citrate Citric acid + Na-citrate 1-3%
Phosphate H3PO4 + Hs salt 0.8-2%
Carbonate H2CO3 + NaHCO3 1-2%
Features of buffering agent:
• It should have a low toxicity.
• It should be buffered at the range of 7.4 as the pH of the body is 7.4.
• It should be non-irritant.
Examples of buffering agent: Most of the buffering system are based on carbonate, citrates,
gluconates , lactates, phosphates, or tartrates etc.
Shamiul Bashar
1st
Batch
B. Pharm, VU
21
Pharmaceutical Excipients
Surfactants
Surfactants are compounds that lower the surface tension (or interfacial tension) between two
liquids or between a liquid and a solid and increase the solubility. They are also known as surface
active agents.
They may be used as emulsifying agents, detergents, solubilising agents, wetting agents, foaming
agents. antifoarning agents, flocculating agents and deflocculating agents.
Properties of surfactants: A surfactant must fulfill two structural requirements-
a) A surfactant must contain a lipophilic region.
b) A surfactant must contain a hydrophilic region.
In a surfactant both hydrophilic and lipophilic region must be balanced because then both the regions
will be concentrated at an interface and therefore surface tension will be lowered.
Types of surfactants: There are of four types of surfactants based on the charge of the hydrophilic
region:
1. Anionic surfactant ( here the hydrophilic region is negatively charged i.e. an anion)
Sodium lauryl sulphate - It is used as an excipient on some dissolvable aspirins and other
fiber therapy caplets.
2. Cationic surfactant (here hydrophilic region is positively charged i.e. a cation)
Cetyl trimethyl ammonium bromide (cetrimide) - is an effective antiseptic agent against
bacteria and fungi.
3. Non-ionic surfactants :
Tween 80 ( polyoxyethylene sorbitol monooleate)- Polysorbate 80 is an excipient that is used
to stabilize aqueous formulations of medications for parenteral administration
Span (sorbitan ester of lauric acid)
4. Amphoteric surfactant :
Lecithin- it acts as a wetting, stabilizing agent and a choline enrichment carrier, helps in
emulsifications and encapsulation, and is a good dispersing agent.
N-dodecyl alanine.
Q. Write down the mechanism action of surfactant.
The molecules of a surfactant consist of two parts, i.e. a polar part and non-polar part. When such
molecules are placed in two phases of different polarities the polar part moves towards high polarity
phase while non-polar part moves towards the low polarity phase and phase and preferentially they
are absorbed at the interphase. As the concentration is increased a level is reached where the
interphase becomes saturated with surface active agent and no more space is available at the surface
to be occupied. Therefore the surfactant molecules move towards the bulk of the solution. At this
concentration an unusual phenomenon occurs. The molecules tend to form colloidal aggregates
known as micelles consisting of 50 to 150 molecules of surface active agents. The concentration of
surfactant at which the micelles are formed is known as critical micelle concentration or C.M.C. The
solubilization begins at C.M.C and generally increases with increase the concentration of micelles.
Q. Define micelle and CMC.
Micelle: The colloidal aggregate molecules consisting of 50 to 150 molecules of surface active
agents known as micelles.
C.M.C: The concentration of surfactant at which the micelles are formed is known as critical
micelle concentration or C.M.C.
Shamiul Bashar
1st
Batch
B. Pharm, VU
22
Pharmaceutical Excipients
Q. Elucidate the choice of emulsifying agents.
To get an emulsion of required properties, the emulsifying agent selected must have the following
qualities.
1. It should be capable of reducing the interfacial tension between the two immiscible
liquids.
2. It should be capable of keeping the globules of dispersed liquid distributed indefinitely
throughout the dispersion medium.
3. It should be non-toxic,
4. The odour and taste should be compatible with the preparation.
5. It should be chemically compatible with other ingredients of the preparation.
6. It should be able to produce and maintain the required consistency of the preparation.
Viscosity imparting agents
Viscosity imparting agents: These agents are used when it is desirable to increase or decrease the
viscosity of a liquid either to serve as adjacent for palatability or to improve pour ability. They are
also called thickening agents.
Some viscosifiers go into solution, such as certain cellulose based polymers, resulting in a Newtonian-
type viscosity. Other materials increase viscosity, while imparting a yield stress to the
suspension. This type of product is known as thixotrope.
Viscosity imparting agents are of two types:
1. Viscosity modifier-Viscosity modifiers decrease the viscosity of a liquid to improve pour
ability and make it more palatable.
2. Viscosity enhancer- Viscosity enhancers increase the viscosity of a liquid to improve pour
ability and make it more palatable.
Most commonly used viscosity imparting agents are: Acacia, Agar, Sodium alginate, Bentonite,
Carbomer, Carboxymethyl cellulose sodium (CMC), Guar gum, Hydroxypropyl cellulose (HPC),
Hypromellose (HPMC), Methylcellulose, Pectin, Hydroxyethylcellulose, Polyvinyl alcohol (PVA),
Polyvinylpyrrolidone (PVP)
Humectant
Humectant is a group of hygroscopic substances used to keep things moist. It is the opposite of a
desiccant. They are used in many products including food, cosmetics, medicines and pesticides.
Function: Their function is to retard evaporation of aqueous vehicle of dosage form-
• To prevent drying of the product after application to the skin
• To prevent drying of product from the container after first opening
• To prevent cap-locking caused by condensation onto neck of container closure of a container
after first opening
N.B: Cap-locking involves liquid products that recrystallized at the bottle-cap interface and makes
opening the bottle difficult after prolonged periods of non-use. These materials are hygroscopic and
should be stored in well closed containers prior to use.
Typical features of humectant: An ideal humectant should have the following criteria-
1. It must absorb moisture from atmosphere and retain the same under the normal conditions of
atmospheric humidity.
2. It should be colorless or not of too intense color.
Shamiul Bashar
1st
Batch
B. Pharm, VU
23
Pharmaceutical Excipients
3. It should have good odor and taste.
4. It should be nontoxic and nonirritant.
5. It should be noncorrosive to packaging materials
6. It should not solidify under normal conditions.
7. It should not be too costly.
Classification of humectants with examples: There are three types of humectants such as inorganic
humectants, metal organic humectants and organic humectants.
1. Inorganic humectants: These are limited used in cosmetics. Calcium chloride is an example.
It has compatibility problems and corrosive in nature. Hence it is not frequently used in
cosmetics.
2. Metal organic humectants: These are limited used in cosmetics because of compatibility
problems, corrosive nature and pronounced taste. The example of this class is sodium lactate.
3. Organic humectants: These are widely used in cosmetics. They include polyhydric alcohols,
their esters and ethers. The most commonly used organic humectants are glycerol, ethylene
glycol, polyethylene glycol (PEG), diethylene glycol, tri ethylene glycol, propylene glycol,
dipropylene glycol, glycerin, sorbitol, mannitol, glucose.
Mode of action:
• A humectant attracts and retains the moisture in the nearby air via absorption, drawing the
water vapor into and/or beneath the organism/object's surface.
• By contrast, desiccants also attract ambient moisture, but adsorbs -- not absorbs -- it, by
condensing the water vapor onto the surface, as a layer of film.
• Humectants absorb water vapors from atmosphere till a certain degree of dilution is attained.
Aqueous solutions of humectants can reduce the rate of loss of moisture.
Wetting Agents
To aid ‘wetting’ and dispersion of a hydrophobic API, preservative or antioxidant
 Reduce interfacial tension between solid and liquid during manufacture or reconstitution of a
suspension
 Not all are suitable for oral administration
Examples include:
 Surface active agents, e.g.
• Oral: polysorbates (Tweens), sorbitan esters (Spans)
• Parenteral: polysorbates, poloxamers, lecithin
• External: sodium lauryl sulphate
But these can cause excessive foaming (see anti-foaming agents) and can lead to
deflocculation and undesirable physical instability (sedimentation) if levels too high
 Hydrophilic colloids that coat hydrophobic particles, e.g. bentonite, tragacanth, alginates,
cellulose derivatives. Also used as suspending agents, these can encourage deflocculation if
levels are too low.
Shamiul Bashar
1st
Batch
B. Pharm, VU
24
Pharmaceutical Excipients
Anti-Foaming Agent
Q. Define anti-foaming agent with examples.
Anti-foaming: A defoamer or an anti-foaming agent is a chemical additive that reduces and
hinders the formation of foam in industrial process liquids by reducing interfacial tension between
two phases.
Example: Insoluble oils. polydimethylsiloxanes and other silicones, certain alcohols, stearates
and glycols, Simethicone (polydimethylsiloxane-silicon dioxide).
Q. Why anti-foaming agents are used in industrial process?
In industrial processes, foams pose serious problems. They cause defects on surface coatings.
They prevent the efficient filling of containers. So, anti-foaming agents are used in industrial process
to prevent formation of foams.
Q. Write down the properties of an anti-foaming agent.
Properties of an anti-foaming agent:
1. It should be insoluble in the foaming medium.
2. It should be surface active.
3. Should have low viscosity.
4. It should spread rapidly on foamy surfaces.
5. It has affinity to the air-liquid surface where it destabilizes the foam lamellas.
Q. Write down the classification of anti-foaming agents.
Classification of anti-foaming agents: Anti-foaming agents are classified into the following
types.
1. Oil based anti-foaming agents: Oil based anti-foaming agents have an oil carrier. The oil
might be mineral oil, vegetable oil, white oil or any other oil that is insoluble in the foaming medium
except silicone oil. An oil based defoamer also contains a wax and/or hydrophobic silica to boost the
performance. Typical waxes are ethylene bis stearamide (EBS), paraffin waxes, ester waxes and fatty
alcohol waxes. These products might also have surfactants to improve emulsification and spreading in
the foaming medium.
2. Powder anti-foaming agents: Powder anti-foaming agents are in principle oil based
defoamers on a particulate carrier like silica. These are added to powdered products like cement,
plaster and detergents.
3. Water based anti-foaming agents: Water based anti-foaming agents are different types of
oils and waxes dispersed in a water base. The oils are often white oils or vegetable oils and the waxes
are long chain fatty alcohol, fatty acid soaps or esters. These are normally best as deaerator, which
means they are best at releasing entrained air.
4. Silicone based anti-foaming agents: Silicone-based anti-foaming agents are polymers with
silicon backbones. These might be delivered as oil or a water based emulsion. The silicone compound
consists of hydrophobic silica dispersed in silicone oil. Emulsifiers are added to ensure that the
silicone spreads fast and well in the foaming medium. The silicone compound might also contain
silicone glycols and other modified silicone fluids.
Q. Write down the applications of anti-foaming agents.
Applications of anti-foaming agents:
1. Detergents: Anti-foams are added in certain types of detergents to reduce foaming that might
decrease the action of the detergent. For example dishwasher detergents have to be low foaming for
the dishwasher to work properly.
Shamiul Bashar
1st
Batch
B. Pharm, VU
25
Pharmaceutical Excipients
2. Food: When used as an ingredient in food, antifoaming agents are intended to curb effusion
or effervescence in preparation or serving. The agents are included in a variety of foods such as
chicken nuggets in the form of polydimethylsiloxane (a type of silicone). Silicone oil is also added to
cooking oil to prevent foaming in deep-frying.
3. Industrial use: Defoamers are used in many industrial processes and products: wood pulp,
paper, paint, industrial wastewater treatment, food processing, oil drilling, machine tool industry, oils
cutting tools, hydraulics etc.
4. Pharmaceuticals: Antifoaming agents are also sold commercially to relieve bloating. A
familiar example is the drug Simethicone, which is the active ingredient in drugs such as Entacyd
plus.
Plasticizer
Q. Define plasticizer. Why plasticizer needed for film coating?
Plasticizer: Plasticizers lower the glass transition temperature of polymers, specifically polymers
used for coatings. By lowering the glass transition temperature, the polymers can partially melt, and
the droplets can coalesce to form a completely sealed coating on a tablet or spheroid at a lower
temperature, thus, preventing the active from being exposed to elevated processing temperatures. This
affords better, more consistent release of the active. e.g.,
Commonly used plasticizers are Glycerin, Propylene Glycol, Triacetin, Triethanolamine, castor
oil, PG, Glycerin, lower molecular weight (200- 400 series), PEG, surfactants etc. For aqueous
coating PEG and PG are more used while castor oil and spans me primarily used for organic-solvent
based coating solution. External plasticizer should he soluble in the solvent system used for dissolving
the film former and plasticizer.
Recommended levels of plasticizers range from 1-50% by weight of the film former. Plasticizers
are normally used at concentration between 15-35% based on polymer weight. .
Plasticizer need for film coating because
1. Plasticizers are low molecular weight organic solvents with high boiling points. They are
used to alter the physical properties of a polymer (i.e. hard or brittle) and render it more
flexible and softer to function as a film-coating material.
2. Plasticizers also have a significant influence on mechanical properties of the film.
3. Specifically, they can reduce cohesive intermolecular forces along the polymer chains and
enhance flexibility by increasing strain or film elongation and decreasing tensile strength
and elastic modulus of the polymer.
4. Additionally, they influence the permeability characteristics of the film, especially to
water vapor, as well as lowering the glass transition temperature of the polymer to allow
a more feasible coaling process.
5. Plasticizers also possess solvent power to insure compatibility with the polymer.
6. Plasticization time (i.e. mixing time of plasticizer with polymer) and plasticizer level
influence the nature of the polymer films.
Q. Classify plasticizer.
Types of plasticizers: Three types of plasticizers are commonly used in pharmaceutical coating
processes:
a. Polyols: Water miscible
1. Glycerol (glycerin)
2. Propylene glycol (PG)
3. Polyethylene glycol (PEG 200-6000 grades)
Shamiul Bashar
1st
Batch
B. Pharm, VU
26
Pharmaceutical Excipients
b. Organic esters:
1. Diethyl phthalate (DEP) – water insoluble
2. Dibutyl phthalate (DBP) - water insoluble
3. Dibutyl sebacate (DBS) – water insoluble
4. Triethyl citrate (TEC) - water miscible
5. Acetyltriethyl citrate ( ATEC) - water insoluble
c. Oils/glycerides: water insoluble
1. Castor oil
2. Distilled acetylated monoglycerides
3. Fractionated coconut oil
Tonicity contributors
Q. What do you mean by tonicity contributors? Give example with used concentration.
Tonicity contributors: Tonicity contributors are the substances which are often included in
parenteral product particularly in large volume preparation to make it isotonic with blood or other
body fluid.
Commonly used tonicity contributor
Name Concentration Name Concentration
1. NaCl 0.9% 2. Lactose 5.0%
3. Dextrose 5.5% 4. Glycerine 2.25%
5. Mannitol 2.5%
Q. Why tonicity contributors are used in pharmaceutical formulation?
The compound which are used as tonicity contributors, reduce the pain at the site of injection.
Adjustment of tonicity to isotonic condition is important, inorder to prevent the integrity of RBC by
the addition of NaCl, Borax etc.
Q. Define hypertonic, hypotonic and isotonic solution.
Isotonic solution: The solutions that have same osmolarity to the blood or other body fluid are
known as isotonic solution. i.e. 0.9% solution of sodium chloride is isotonic with plasma.
Hypotonic solution: The solutions that have low osmolarity than the blood or other body fluid
are known as hypotonic solution. i.e. 0.45% solution of sodium chloride hypotonic with plasma.
Hypertonic solution: The solutions that have high osmolarity than the blood or other body fluid
are known as hypertonic solution. i.e. 5% solution of sodium chloride hypertonic with plasma.
Q. Problem with hypertonic and hypotonic solution in human body.
The solutions which are not isotonic with plasma may be harmful to use. On injecting the
hypotonic solutions into blood stream. It may enter the red blood cells in an attempt to produce
equilibrium. The cells swell rapidly until they burst leading to haemolysis. As this damage is
irreversible it may lead to serious danger to red blood cells.
When hypertonic solution is injected into the blood stream, the water comes out of the membrane
of red blood cells in order to reach equilibrium. The cells shrink leading to crenulation which is only a
temporary damage. When the osmotic pressure of two solutions becomes equal the damaged cells will
come to their original position. Hence hypertonic solutions may therefore be administered without
permanent damage to the blood cells. They should be injected slowly to ensure rapid dilution into the
blood stream and to minimize the crenulation of blood cells
Shamiul Bashar
1st
Batch
B. Pharm, VU
27
Pharmaceutical Excipients
Q. Write down the general principle for adjustment to tonicity and problems.
General principle for adjustment to tonicity:
Calculations for solutions iso-osmotic with blood and tear: There are generally two methods
for adjustment of tonicity. These ares-
1. Based on freezing-point data.
2. Based on molecular concentration.
1. Based on freezing-point data:
0.52 − 𝑎
𝑏
Where,
a = Freezing-point of unadjusted solution.
b = Freezing-point of a 1% w/v solution of
the adjusting substance.
2. Based on molecular concentration:
i. For non-ionising solute
𝑊 = 0.3𝑀
ii. For ionising solute
𝑊 =
0.3𝑀
𝑁
Where,
W = Concentration required in g per liter.
M = Molecular weight of the
N = Number of ion produce from each
molecule of the solute assuming that
dissociation is completed
Problem 1: What concentration of Procain Hydrochloride will yield a solution iso-osmotic with
blood plasma?
Ans: Freezing point of 1% w/v solution of Procain Hydrochloride is -0.122°C
∴ Precentage w v⁄ of Procain Hydrochloride required =
0.52 − 0.00
0.122
= 4.26% w v⁄
Problem 2: Find the concentration of sodium chloride required to prepare a 1% solution of
Cocaine Hydrochloride iso-osmotic with blood plasma.
Ans: Freezing point of a 1% w/v solution of Cocaine Hydrochloride is -0.09°C and that of 1%
w/v solution of sodium chloride is -0.576°C.
∴ Precentage w v⁄ of sodium chloride required =
0.52 − 0.09
0.576
= 0.746% w v⁄
Problem 3: Find the concentration of sodium chloride required to render a 1.5% solution of
Procaine Hydrochloride iso-osmotic with blood plasma.
Ans: Freezing point of a 1% w/v solution of procaine Hydrochloride is -0.122°C and that of 1%
w/v solution of sodium chloride is -0.576°C.
∴ Precentage w v⁄ of sodium chloride required =
0.52 − (0.122 × 1.5)
0.576
= 0.585% w v⁄
Problem 4: Find the concentration of anhydrous dextrose needed to produce a solution iso-
osmotic with blood plasma.
Ans: The molecular weight of dextrose is 180 and it is non-ionising.
∴ 0.3 × 180 = 54 g per litre is required
(The B. P. uses 5%)
Problem 5: Find the concentration of boric acid required to produce a solution iso-osmotic with
lachrymal secretion.
Ans: The molecular weight of boric acid is 62 and it is a partially non-ionising.
∴ 0.3 × 62 = 18.6 g per litre (1.86% w v)⁄
Shamiul Bashar
1st
Batch
B. Pharm, VU
28
Pharmaceutical Excipients
Formula Nomenclature
CCl3F CFC-11
CCl2F2 CFC-12
C2Cl2F4 CFC-114
Problem 6: Find the concentration of sodium chloride required to produce a solution iso-osmotic
with blood plasma.
Ans: The molecular weight of sodium chloride is 58.8 and it dissociates into 2 ions.
∴
0.3 × 58.5
2
= 8.8 g per litre (0.88% w v)⁄
(The B. P. uses 0.90%)
Propellants
Q. Define aerosol with its composition and give its purpose of use.
Aerosol: An aerosol or pressurized package is defined as "a system that depends on the power of
a compressed or liquefied gas to expel the contents from the container."
Composition:
1. Product concentrates: i. Active ingredient. ii. Surface active agents. iii. Antioxidant.
2. Propellant.
An examination of the aerosol dosage form reveals the following specific advantages over other
dosage forms:
1. A dose can be removed without contamination of remaining material. Stability is
enhanced for those substances adversely affected by oxygen and/or moisture. When
sterility is an important factor, it can be maintained while a dose is being dispensed.
2. The medication can be delivered directly to the affected area in a desired form, such as
spray, stream, quick-breaking foam, or stable foam.
3. Irritation produced by the mechanical application of topical medication is reduced or
eliminated.
Other advantages are ease and convenience of application and application of medication
in a thin layer.
Q. What do you mean by propellants and classify it.
Propellant: Propellants are the substances which are used for aerosol preparation to exert/ create
vapour pressure.
i.e.
1. HFA: HFA-227, HFA-134a
2. CFC: CFC-11, CFC-12, CFC-114
3. Compressed gas: Nitrogen, argon.
Classification of propellants: The propellants used in aerosol system may be classified into
1. Liquified gases:
a. Fluorinated hydrocarbons
b. Hydrocarbons
2. Compressed gases:
a. Insoluble in water, i.e. nitrogen, argon, and
b. Soluble in water, i.e. carbon dioxide,
nitrous oxide.
Q. Write down the nomenclature of CFC and HFA.
CFCs and HFAs are numbered using a universal system.
1. The first digit is the number of carbon atoms minus 1 (omitted if zero).
2. The second is the number of hydrogen atoms plus 1.
3. The third is the number of fluorine atoms.
Chlorine fills any remaining valencies, given the total number of atoms required to saturate the
compound. If asymmetry is possible, this is designated by a letter.
i.e.
Shamiul Bashar
1st
Batch
B. Pharm, VU
29
Pharmaceutical Excipients
Q. Briefly describe Raoult’s law of vapour pressure.
Raoult's Law: The vapour pressure of a mixed system is equal to the sum of the mole fraction of
each, component multiplied by its vapour pressure.
P = Pa + Pb
Where P is the total vapour pressure of the system and Pa and Pb are the partial vapour pressures
of the components, a and b.
Pa = 𝑥aPa
0
Pb = 𝑥bPb
0
Where xa and xb are the mole fractions and Pa
0
and Pb
0
are the vapour pressures of components a
and b, respectively.
Q. Why use of CFCs as propellant decreased day by day than HFAs.
CFCs are friendly to ozone in the earth's stratosphere. The reaction of CFCs with the ozone in the
earth's stratosphere, which absorbs ultraviolet radiation at 300 nm, and their contribution to global
warming are major environmental concerns. CFCs pass to the stratosphere, where in the presence of
UV they liberate chlorine, which reacts with ozone. The depletion of stratospheric ozone results in
increased exposure to the UV-B part of the UV spectrum, resulting in a number of adverse effects, in
particular an increased incidence of skin cancer. The Montreal Protocol of 1987 was a global ban on
the production of the five worst ozone-depleting CFCs by the year 2000, This was amended in 1992,
so that production of CFCs in developed countries was phased out by January 1996. In the European
Union, all ozonedepleting CFCs were banned by the end of 1995.
HFAs are friendly to ozone in the earth’s stratosphere and do not cause such complication like
CFCs.
This is the reason that the use of CFCs as propellant decreased day by day than HFAs.
Desiccant
Q. Define desiccant with examples.
Desiccant: A desiccant is a hygroscopic substance that induces or sustains a state of dryness
(desiccation) in its vicinity. Commonly encountered pre-packaged desiccants are solids that absorb
water. Desiccants for specialized purposes may be in forms other than solid and may work through
other principles, such as chemical bonding of water molecules. They are commonly encountered in
foods to retain crispness. Industrially, desiccants are widely used to control the level of water in gas
streams.
The most common desiccant is silica, an otherwise inert, nontoxic, water-insoluble white solid.
Tens of thousands of tons are produced annually for this purpose. Other desiccants include activated
charcoal, calcium sulfate, calcium chloride, and molecular sieves (typically, zeolites).
 Why silica is used as desiccant in pharmaceutical industry?
Q. How can you measure the efficiency of a desiccant?
Performance efficiency
One measure of desiccant efficiency is the ratio (or precentage) of water storable in the desiccant
relative to the mass of desiccant.
Another measure is the residual relative humidity of the air or other fluid being dried.
The performance of any desiccant varies with temperature and both relative humidity and
absolute humidity. To some extent, desiccant performance can be precisely described, but most
commonly, the final choice of which desiccant best suits a given situation, how much of it to use and
in what form, is made based on testing and practical experience.
Shamiul Bashar
1st
Batch
B. Pharm, VU
30
Pharmaceutical Excipients
Q. Write down the applications of desiccant.
Applications of desiccant:
1. It is used in the manufacture of insulated windows where zeolite spheroids fil a rectangular
spacer tube at the perimeter of the panes of glass. The desiccant helps to prevent the condensation of
moisture between the panes. Another use of zeolites is in the dryer component of air conditioning
systems to help maintain the efficacy of the refrigerant. Desiccants are also commonly used to protect
goods in shipping containers against moisture damage. Hygroscopic cargo, such as cocoa, coffee and
various nuts and grains are particularly susceptible to mold and rot when exposed to condensation and
humidity. Because of this, shippers often take precautionary measures to protect against cargo loss.
2. Desiccants induce dryness in any environment and reduce the amount of moisture present in
air. Desiccants come in various forms and have found widespread use in the food, pharmaceuticals,
packing, electronics and many manufacturing industries.
3. Drying of solvents: Toluene is refluxed with sodium and benzophenone to produce dry,
oxygen free toluene. The toluene is dry and oxygen free when the intense blue coloration from the
benzophenone ketyl radical is observed.
4. Desiccants are also used to remove water from solvent typically required by chemical
reactions that do not tolerate water, e.g., the Grignard reaction. The method generally, though not
always. involves mixing the solvent with the solid desiccant. The dried solvent is then separated by
the desiccant by filtration or distillation.
Acidifying agents
Acidifying agents will lower the pH of the solution. They are typically derived from phosphoric
acid or blends of phosphate ester anionic surfactants containing free phosphoric acid. Their primary
use is with insecticides when there is a need to prevent alkaline hydrolysis by lowering pH of the
spray solution
Urinary Acidifying Agents
1. Citric acid
2. Magnesium carbonate
3. Potassium acid phosphate
4. Renacidin
Alkalinizing agent
Alkalinizing agents are drugs used to manage disorders associated with low pH. For example,
they may be used to treat acidosis due to renal failure. Used for oral or parenteral therapy, sodium
bicarbonate is the commonly preferred alkalinizing agent. Others include potassium citrate, calcium
carbonate, sodium lactate and calcium acetate. Alklinizing agent excipients are important in
pharmaceutical formulations where the active pharmaceutical ingredient requires an alkaline
environment for stability or therapeutic effectiveness.
 Sodium bicarbonate
 Sodium citrate/citric acid
 Sodium lactate
 Ammonia Solution
 Ammonium Carbonate
Alkaline agents are used to balance the acids of our body and to strengthen the effect of cleaning
solutions. Maintaining a proper potential hydrogen (pH) level is vital to our health, keeping
cholesterol, blood sugar and the heart's circular system running smoothly. If pH level is kept at 7, the
alkaline and acids are equally balanced, influencing bone health, proper digestion, electrolyte activity
and keeping immunity strong to prevent sickness.
Shamiul Bashar
1st
Batch
B. Pharm, VU
31
Pharmaceutical Excipients
Air Displacement Agents
Air displacement agents: Substances employed to displace air in a hermetically sealed container
to enhance product stability. (e.g. nitrogen. carbon dioxide).
Anticaking agent
An anticaking agent is an additive placed in powder or granulated materials, such as table salt, to
prevent the formation of lumps and for easing packaging, transport and consumption.
An anticaking agent in salt is denoted in the ingredients, for example, as "anti-caking agent
(554)", which is sodium aluminosilicate, a man-made product. This product is present in many
commercial table salts as well as dried milk, egg mixes, sugar products and flours. In Europe, sodium
ferrocyanide (535) and potassium ferrocyanide (536) are more common anticaking agents in table
salt. Natural anticaking agents used in more expensive table salt include calcium carbonate and
magnesium carbonate.
Some anticaking agents are soluble in water; others are soluble in alcohols or other organic
solvents. They function either by absorbing excess moisture or by coating particles and making them
water repellent. Calcium silicate (CaSiO3) a commonly used anti-caking agent, added to e.g. table salt,
absorbs both water and oil.
Anticaking agents are also used in non-food items such as road salt, fertilizers, cosmetics,
synthetic detergents and in manufacturing applications.
List of anticakiug agents: The following anticaking agents are listed in order by their E number.
 E341 tricalcium phosphate
 E460(ii) powdered cellulose
 E470b magnesium stearate
 E500 sodium bicarbonate
 E535 sodium ferrocyanide
 E536 potassium ferrocyanide
 E538 calcium ferrocyanide
 E542 bone phosphate
 E550 sodium silicate
 E551 silicon dioxide
 E552 calcium silicate
 E553a magnesium trisilicate
 E553b talcum powder
 E554 sodium aluminosilicate
 E555 potassium aluminium silicate
 E556 calcium aluminosilicnte
 E558 bentonite
 E559 aluminium silicate
 E570 stearic acid
 E900 polydimethylsiloxane
Water repellent
OWR (durable water repellent) is a coating added to fabrics at the factory to make them water-
resistant (or hydrophobic). Most factory-applied treatments are fluoropolymer based. Durable water
repellents are commonly used in conjunction with waterproof breathable fabrics such as Gore-Tex to
prevent the outer layer of fabric from becoming saturated with water. This saturation called 'wetting
out,' can reduce the garment's breathabilitv (moisture transport through the breathable membrane) and
Shamiul Bashar
1st
Batch
B. Pharm, VU
32
Pharmaceutical Excipients
let water through. As the DWR wears off over time, re-treatment is recommended when necessary.
Many spray-on and wash-in products for treatment of non-waterproof garments and re-treatment of
proofed garments losing their water-repellency are available from sources of sporting apparel. Sprays
are made of Grangers, Nikwax, McNett, Trek7 and others.
Older methods for factory application of DWR treatments involve applying a solution of a
chemical onto the surface of the fabric by spraying or dipping. More recently the chemistry is applied
in the vapor phase using Chemical Vapor Deposition (CVD) machinery. The advantages of CVD
include: (1) It eliminates the use of hazardous and environmentally harmful solvents in the application
process; (2) The process requires less chemical; (3) the waterproof layer is extremely thin and has less
effect on the natural look and feel or the fabric. Later advances have eliminated perfluorinated acids
considered to be potentially hazardous to human health by the US Environmental Protection Agency,
from the application process.
Q. How silicone water repellents work.
Silicone water repellents or waterproofing agents generally come in two forms:
1. Elastomeric polydimethylsiloxanes - elastomeric coatings that adhere to the substrate and
cure to form a flexible, protective membrane.
2. Penetrating water-repellent chemicals- reactive silanes and siloxane resins with
crosslinkable side chains. These materials have smaller molecular structures which enable
them to penetrate deeply into the substrate, where they chemically bond with it.
Either of these materials can be delivered via solvent or aqueous emulsion.
Q. Write a shot note on the following excipient.
a. Acacia
b. Tragacanth
c. Lactose, Monohydrate and Microcrystalline Cellulose
Sialagogues
These materials are usually acidic, and their purpose in a formulation is to stimulate the production of
saliva. They are mostly found in chewable products for children or in gum-based products. By
facilitating the production of saliva, the masticated product is swallowed more readily, limiting the
objectionable flavor of the active from lingering too long.
Example: Citric acid, Fumaric acid, Tartaric acid
Shamiul Bashar
1st
Batch
B. Pharm, VU
33
Pharmaceutical Excipients
Excepient toxicity
 Propylene Glycol Toxicity (Class: Solvent/ preservatives)
 Propylene glycol (PG) is a general solvent with anti-microbial properties used in a wide range
of pharmaceutical preparations including oral liquids, topicals and parenteral preparations
 However, it’s use in large volumes in children is very much discouraged:
• PG has been associated with cardiovascular, hepatic, respiratory and CNS adverse events,
especially in neonates where the biological half-life is prolonged (~17h) compared with
adults (5h).
• I.V. parenterals containing PG must be infused slowly
• PG also has a laxative action at high oral doses through high osmotic pressure effects.
 Ethanol Toxicity (Class: Solvent)
 Widely used as a co-solvent to aid solubility
 In US, maximum permitted quantities in OTC products:
• <0.5% for children under 6-years
• <5% for children 6-12-years
• <10% for children over 12-years
 Acute (overdose) or chronic (long-term use) toxicity is possible
 May cause adverse symptoms of intoxication, lethargy, stupor, coma, respiratory depression
and cardiovascular collapse
 Peanut Oil Toxicity (Class: Solvent)
 Peanut oil is used as a food additive and as a solvent in intra-muscular injections
 It has been suggested that the use of peanut oil in childhood (infant formula and topical
preparations) can lead to later episodes of hypersensitivity, and therefore should be
discontinued
 Saccharin (Class: Sweetener)
 Restricted regulatory acceptability
 Poor aftertaste
 Hypersensitivity reactions; mainly dermatologic
 Paediatrics with allergy to sulphonamides should avoid saccharin
 Aspartame Toxicity (Class: Sweetener)
 Source of phenylalanine – possibly an issue for phenylketoneurics
 Aspartame has been blamed for hyperactivity in children but as yet unproven
 Sorbitol (Class: Sweetener)
 Can induce diarrhea
 Benzyl Alcohol toxicity in neonates (Class: Anti-microbial preservatives)
 Widely used as a preservative in cosmetics, foods and pharmaceuticals (including injectables
and oral liquids)
 Toxic syndrome observed in neonates – it was attributed to the practice of “flushing out”
umbilical catheters with solutions containing benzyl alcohol (BA), because of trace levels of
benzaldehyde that were present
 Dilution of nebulisation solutions with BA-preserved saline led to severe respiratory
complications and even death in neonates. Attributed to accumulation of BA due to an
immature metabolic capability.
Shamiul Bashar
1st
Batch
B. Pharm, VU
34
Pharmaceutical Excipients
 Sodium Benzoate toxicity (Class: Anti-microbial preservatives)
 Widely used as a preservative in cosmetics, foods and pharmaceuticals (including injectables
and oral liquids)
 Injectable combinations of Na Benzoate and Caffeine should not be used in neonates; found
to elicit non-immunological contact reactions, including urticaria and atopic dermatitis
 Limitation on dosing of Na benzoate to neonates - ≤10mg/kg/day – due to immature
metabolic capability
 Thimerosal toxicity (Class: Anti-microbial preservatives)
 Formerly widely used as a preservative in cosmetics, in soft contact lens solutions and
pharmaceuticals (primarily vaccines)
 Being phased out from most paediatric vaccines as better options emerge
 Possible links with toxicity in paediatric vaccines, e.g. childhood autism, have been
discounted after much debate
 Lactose toxicity (immature metabolism) (Class: Diluents/ Filler)
 Lactose occurs widely in dairy products and is used in infant feed formulae.
 In pharmaceutical preparations it is widely used as a diluent in tablets and capsules, in
lyophilised powders, as a sweetener in liquid formulations and as a carrier in dry powder
inhalation products.
 Lactose intolerance occurs when there is a deficiency in the intestinal enzyme lactase, leading
to GIT build-up of lactose. There is then the risk of abdominal bloating and cramps.
 Lactase is normally present at high levels at birth; declining rapidly in early childhood (4-8
years) Hypolactasia (malabsorption of lactose) can thus occur at an early age and,
furthermore, this varies among different ethic groups.
 Significant lactose intolerance can also occur in adults but this is rare.
Shamiul Bashar
1st
Batch
B. Pharm, VU
35
Pharmaceutical Excipients
Use of Different Excipients
Sl. Excipient Use
1 Acacia Emulsifying agent; stabilizing agent; suspending agent; tablet
binder; viscosity-increasing agent
2 Alginate Binder
3 Alginic Acid Stabilizing agent; suspending agent; tablet binder, tablet
disintegrant; viscosity-increasing agent.
4 Aluminum Acetate Antiseptic
5 Benzyl Alcohol Antimicrobial preservative; disinfectant; solvent
6 Butyl Paraben Antimicrobial preservative
7 Butylated Hydroxy Toluene Antioxidant.
8 Citric acid Disintegrant
9 Calcium carbonate Tablet and capsule diluent; therapeutic agent
10 Candelilla wax Binder
11 Croscarmellose sodium Tablet and capsule disintegrant
12 Confectioner sugar Sugar coating adjunct; sweetening agent; tablet and capsule
diluents
13 Colloidal silicone dioxide Adsorbent; anticaking agent; emulsion stabilizer; glidant;
suspending agent; tablet disintegrant; thermal stabilizer;
viscosity-increasing agent.
14 Cellulose Adsorbent; suspending agent; tablet and capsule diluent;
tablet disintegrant.(cellulose microcrystaline) Adsorbent; glidant;
suspending agent;
tablet and capsule diluent; tablet disintegrant (cellulose
powdered) Tablet and capsule diluent.(cellulose Silicified)
15 Plain or anhydrous calcium
phosphate
Diluent
16 Carnuba wax Binder
17 Corn starch Binder
18 Carboxymethylcellulose
calcium
Stabilizing agent; suspending agent;
tablet and capsule disintegrant;
viscosity-increasing agent; water-absorbing agent
19 Calcium stearate Tablet and capsule lubricant
20 Calcium disodium EDTA Chelation
21 Copolyvidone Film-former; granulating agent; tablet binder
22 Castor oil hydrogenated Extended release agent; stiffening agent; tablet and capsule
lubricant
23 Calcium hydrogen phosphate
dihydrate
Diluent
24 Cetylpyridine chloride Antimicrobial preservative; antiseptic;
cationic surfactant; disinfectant;
solubilizing agent; wetting agent
25 Cysteine HCL Reducing Agent
26 Crosspovidone Tablet disintegrant.
27 calcium phosphate di or tri
basic
Tablet and capsule diluent Anticaking agent; buffer, nutrient;
dietary supplement;
glidant; tablet and capsule diluent and clouding agent( for calium
phosphage tribasic)
Shamiul Bashar
1st
Batch
B. Pharm, VU
36
Pharmaceutical Excipients
Sl. Excipient Use
28 Dibasic Calcium Phosphate Diluent
29 Disodium hydrogen phosphate Buffering agent
30 Dimethicone Antifoaming agent;emollient
31 Erythrosine Sodium Color
32 Ethyl Cellulose Coating agent; flavoring fixative; tablet binder; tablet filler;
viscosity-increasing agent.
33 Gelatin Coating agent; film-former; gelling agent; suspending agent;
tablet binder; viscosity-increasing agent
34 Glyceryl monooleate Nonionic surfactant
35 Glycerin Antimicrobial preservative; emollient; humectant; plasticizer;
solvent; sweetening agent; tonicity agent
36 Glycine Tonicity
37 Glyceryl monostearate Emollient; emulsifying agent; solubilizing agent; stabilizing
agent; sustained-release ingredient; tablet and capsule lubricant
38 Glyceryl behenate Coating agent; tablet binder; tablet and capsule lubricant
39 Hydroxy propyl cellulose Coating agent; emulsifying agent; stabilizing agent; suspending
agent; tablet binder; thickening agent;
viscosity-increasing agent.
40 Hydroxyl propyl methyl
cellulose
Coating agent; film-former; rate-controlling polymer for
sustained release; stabilizing agent; suspending agent; tablet
binder; viscosity-increasing agent.
41 Hypromellose Coating agent; film-former;
rate-controlling polymer for sustained release; stabilizing agent;
suspending agent; tablet binder; viscosity-increasing agent.
42 HPMC Pthalate Coating agent.
43 Iron oxides or ferric oxide Color
44 Iron oxide yellow Color
45 Iron oxide red or ferric oxide Color
46 Lactose hydrous or anhydrous
or monohydrate or spray dried
Binding agent; diluent for dry-powder inhalers; lyophilization
aid;
tablet binder; tablet and capsule diluent.( lactose anhydrous)
Binding agent; diluent for dry-powder inhalers; tablet binder;
tablet and capsule diluent(lactose monhydrate) Binding agent;
diluent for dry-powder inhalations; tablet and capsule diluent;
tablet and capsule filler.(lactose spray dried)
47 Magnesium stearate Tablet and capsule lubricant
48 Microcrystalline cellulose Adsorbent; suspending agent; tablet and capsule diluent; tablet
disintegrant same as cellulose see above it is just that mcc is usp
49 Mannitol Sweetening agent; tablet and capsule diluent; tonicity agent;
vehicle (bulking agent) for lyophilized preparations
50 Methyl cellulose Coating agent; emulsifying agent; suspending agent;
tablet and capsule disintegrant; tablet binder; viscosity-
increasing agent
51 Magnesium carbonate Tablet and capsule diluent
52 Mineral oil Emollient; lubricant; oleaginous vehicle; solvent
53 Methacrylic acid copolymer Coating
Pharmaceutical excipients
Pharmaceutical excipients

More Related Content

What's hot

Drug excipient Compatibility
Drug excipient CompatibilityDrug excipient Compatibility
Drug excipient CompatibilitySuraj Choudhary
 
Evaluation methods for drug excipients and container interaction
Evaluation methods for drug excipients and container interactionEvaluation methods for drug excipients and container interaction
Evaluation methods for drug excipients and container interactionSagar Savale
 
Pharmaceutical Suspensions and Emulsions
Pharmaceutical Suspensions and EmulsionsPharmaceutical Suspensions and Emulsions
Pharmaceutical Suspensions and EmulsionsPallavi Kurra
 
Evaluation of tablet
Evaluation  of  tabletEvaluation  of  tablet
Evaluation of tablettasirsalman
 
Formulation and development of parenterals
Formulation and development of parenteralsFormulation and development of parenterals
Formulation and development of parenteralsSai Datri Arige
 
Evaluation of dosage forms
Evaluation of dosage formsEvaluation of dosage forms
Evaluation of dosage formsShaik Sana
 
Physical stability tablets & capsules
Physical stability tablets & capsulesPhysical stability tablets & capsules
Physical stability tablets & capsulesShweta Singh
 
Tablet production process by ranjeet singh
Tablet production process by ranjeet singhTablet production process by ranjeet singh
Tablet production process by ranjeet singhRanjeet Singh
 
Granulation and Modern Equipments
Granulation and Modern EquipmentsGranulation and Modern Equipments
Granulation and Modern EquipmentsSarangDalvi
 
Decomposition and stabilization of pharmaceutical products
Decomposition and stabilization of pharmaceutical productsDecomposition and stabilization of pharmaceutical products
Decomposition and stabilization of pharmaceutical productsArshad Khan
 
Tablet Coating Machine
Tablet Coating MachineTablet Coating Machine
Tablet Coating Machinefaysalahmed35
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients Nahid Hasan
 

What's hot (20)

Drug excipient Compatibility
Drug excipient CompatibilityDrug excipient Compatibility
Drug excipient Compatibility
 
Evaluation methods for drug excipients and container interaction
Evaluation methods for drug excipients and container interactionEvaluation methods for drug excipients and container interaction
Evaluation methods for drug excipients and container interaction
 
Suspension ppt
Suspension pptSuspension ppt
Suspension ppt
 
Pharmaceutical Suspensions and Emulsions
Pharmaceutical Suspensions and EmulsionsPharmaceutical Suspensions and Emulsions
Pharmaceutical Suspensions and Emulsions
 
Evaluation of tablet
Evaluation  of  tabletEvaluation  of  tablet
Evaluation of tablet
 
Formulation and development of parenterals
Formulation and development of parenteralsFormulation and development of parenterals
Formulation and development of parenterals
 
Aerosols
AerosolsAerosols
Aerosols
 
Granulation
GranulationGranulation
Granulation
 
DILUENTS AND DISINTEGRANTS
DILUENTS AND DISINTEGRANTSDILUENTS AND DISINTEGRANTS
DILUENTS AND DISINTEGRANTS
 
Tablets ppt
Tablets pptTablets ppt
Tablets ppt
 
Preformulation
PreformulationPreformulation
Preformulation
 
Evaluation of dosage forms
Evaluation of dosage formsEvaluation of dosage forms
Evaluation of dosage forms
 
Physical stability tablets & capsules
Physical stability tablets & capsulesPhysical stability tablets & capsules
Physical stability tablets & capsules
 
Tablet production process by ranjeet singh
Tablet production process by ranjeet singhTablet production process by ranjeet singh
Tablet production process by ranjeet singh
 
Wet granulation
Wet granulationWet granulation
Wet granulation
 
Granulation and Modern Equipments
Granulation and Modern EquipmentsGranulation and Modern Equipments
Granulation and Modern Equipments
 
Decomposition and stabilization of pharmaceutical products
Decomposition and stabilization of pharmaceutical productsDecomposition and stabilization of pharmaceutical products
Decomposition and stabilization of pharmaceutical products
 
Tablet Coating Machine
Tablet Coating MachineTablet Coating Machine
Tablet Coating Machine
 
Tablet Evaluation
Tablet EvaluationTablet Evaluation
Tablet Evaluation
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients
 

Viewers also liked

Viewers also liked (7)

Drug excepients compatability studies
Drug excepients compatability studiesDrug excepients compatability studies
Drug excepients compatability studies
 
Drug.excipient.compatibility
Drug.excipient.compatibilityDrug.excipient.compatibility
Drug.excipient.compatibility
 
Drug excipientinteractions
Drug excipientinteractionsDrug excipientinteractions
Drug excipientinteractions
 
Drug Incompatibility.
Drug Incompatibility.Drug Incompatibility.
Drug Incompatibility.
 
Excipient
ExcipientExcipient
Excipient
 
Pharma excipients antioxidant,acid,alkali,preservative
Pharma excipients  antioxidant,acid,alkali,preservativePharma excipients  antioxidant,acid,alkali,preservative
Pharma excipients antioxidant,acid,alkali,preservative
 
1. preformulation
1. preformulation1. preformulation
1. preformulation
 

Similar to Pharmaceutical excipients

DOSAGE FORMS AND ADDITIVES
DOSAGE FORMS AND ADDITIVESDOSAGE FORMS AND ADDITIVES
DOSAGE FORMS AND ADDITIVESAnantha Kumar
 
Pharmaceutical excipients MANIK
Pharmaceutical excipients MANIKPharmaceutical excipients MANIK
Pharmaceutical excipients MANIKImran Nur Manik
 
Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)SumedhGhodke
 
PCT122 LECTURE 2 2023.pptx
PCT122 LECTURE 2 2023.pptxPCT122 LECTURE 2 2023.pptx
PCT122 LECTURE 2 2023.pptxBatisaniNkobodo
 
TABLETS.sssssssssssssssßssssssddddddddddddd
TABLETS.sssssssssssssssßssssssdddddddddddddTABLETS.sssssssssssssssßssssssddddddddddddd
TABLETS.sssssssssssssssßssssssdddddddddddddakashahirwar318
 
Pharmaceutical excipients
Pharmaceutical excipientsPharmaceutical excipients
Pharmaceutical excipientsHossen M. Faruk
 
Pharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptxPharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptxMohammadShafique24
 
Industrial visit report, Industrial training report
Industrial visit report, Industrial training reportIndustrial visit report, Industrial training report
Industrial visit report, Industrial training reportShiv Kumar
 
pharmaceutical excepients
pharmaceutical excepientspharmaceutical excepients
pharmaceutical excepientsInvisible guest
 
Review on Novel Drug Delivery System and Antihypertensive Tablets
Review on Novel Drug Delivery System and Antihypertensive TabletsReview on Novel Drug Delivery System and Antihypertensive Tablets
Review on Novel Drug Delivery System and Antihypertensive Tabletsijtsrd
 

Similar to Pharmaceutical excipients (20)

Pharmaceutical excipient
Pharmaceutical excipientPharmaceutical excipient
Pharmaceutical excipient
 
DOSAGE FORMS AND ADDITIVES
DOSAGE FORMS AND ADDITIVESDOSAGE FORMS AND ADDITIVES
DOSAGE FORMS AND ADDITIVES
 
Pharmaceutical excipients MANIK
Pharmaceutical excipients MANIKPharmaceutical excipients MANIK
Pharmaceutical excipients MANIK
 
Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)
 
PCT122 LECTURE 2 2023.pptx
PCT122 LECTURE 2 2023.pptxPCT122 LECTURE 2 2023.pptx
PCT122 LECTURE 2 2023.pptx
 
Excipients sb
Excipients sbExcipients sb
Excipients sb
 
TABLETS.pdf
TABLETS.pdfTABLETS.pdf
TABLETS.pdf
 
TABLETS.sssssssssssssssßssssssddddddddddddd
TABLETS.sssssssssssssssßssssssdddddddddddddTABLETS.sssssssssssssssßssssssddddddddddddd
TABLETS.sssssssssssssssßssssssddddddddddddd
 
Tablet excipients
Tablet excipientsTablet excipients
Tablet excipients
 
Pharmaceutical excipients
Pharmaceutical excipientsPharmaceutical excipients
Pharmaceutical excipients
 
Pharmaceutical Excipients
Pharmaceutical Excipients Pharmaceutical Excipients
Pharmaceutical Excipients
 
51 50-1-pb
51 50-1-pb51 50-1-pb
51 50-1-pb
 
Word 1
Word 1Word 1
Word 1
 
Pharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptxPharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptx
 
Industrial visit report, Industrial training report
Industrial visit report, Industrial training reportIndustrial visit report, Industrial training report
Industrial visit report, Industrial training report
 
pharmaceutical excepients
pharmaceutical excepientspharmaceutical excepients
pharmaceutical excepients
 
Review on Novel Drug Delivery System and Antihypertensive Tablets
Review on Novel Drug Delivery System and Antihypertensive TabletsReview on Novel Drug Delivery System and Antihypertensive Tablets
Review on Novel Drug Delivery System and Antihypertensive Tablets
 
Presentation1
Presentation1Presentation1
Presentation1
 
Tablets
TabletsTablets
Tablets
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients
 

Recently uploaded

How to write a Business Continuity Plan
How to write a Business Continuity PlanHow to write a Business Continuity Plan
How to write a Business Continuity PlanDatabarracks
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 
Advanced Computer Architecture – An Introduction
Advanced Computer Architecture – An IntroductionAdvanced Computer Architecture – An Introduction
Advanced Computer Architecture – An IntroductionDilum Bandara
 
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxDigital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxLoriGlavin3
 
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdfHyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdfPrecisely
 
Take control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test SuiteTake control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test SuiteDianaGray10
 
The State of Passkeys with FIDO Alliance.pptx
The State of Passkeys with FIDO Alliance.pptxThe State of Passkeys with FIDO Alliance.pptx
The State of Passkeys with FIDO Alliance.pptxLoriGlavin3
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningLars Bell
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfAddepto
 
Generative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersGenerative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersRaghuram Pandurangan
 
Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Commit University
 
What is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdfWhat is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdfMounikaPolabathina
 
DevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenDevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenHervé Boutemy
 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brandgvaughan
 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek SchlawackFwdays
 
From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .Alan Dix
 
The Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsThe Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsPixlogix Infotech
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsSergiu Bodiu
 
TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024Lonnie McRorey
 

Recently uploaded (20)

How to write a Business Continuity Plan
How to write a Business Continuity PlanHow to write a Business Continuity Plan
How to write a Business Continuity Plan
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 
Advanced Computer Architecture – An Introduction
Advanced Computer Architecture – An IntroductionAdvanced Computer Architecture – An Introduction
Advanced Computer Architecture – An Introduction
 
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxDigital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
 
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdfHyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
 
Take control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test SuiteTake control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test Suite
 
The State of Passkeys with FIDO Alliance.pptx
The State of Passkeys with FIDO Alliance.pptxThe State of Passkeys with FIDO Alliance.pptx
The State of Passkeys with FIDO Alliance.pptx
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine Tuning
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdf
 
Generative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersGenerative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information Developers
 
Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!
 
What is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdfWhat is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdf
 
DevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache MavenDevoxxFR 2024 Reproducible Builds with Apache Maven
DevoxxFR 2024 Reproducible Builds with Apache Maven
 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brand
 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
 
From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .
 
The Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsThe Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and Cons
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platforms
 
TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024
 

Pharmaceutical excipients

  • 1. Shamiul Bashar 1st Batch B. Pharm, VU 1 Pharmaceutical Excipients Q. Define excipients. Why excipients are used in pharmaceutical preparation? Excipient: Drug products contain both drug substance (commonly referred to as active pharmaceutical ingredient or API) and excipients. An excipient is a pharmacologically inactive/ inert substance formulated alongside the active pharmaceutical ingredient of a medication. Excipients play a wide variety of functional roles in pharmaceutical dosage form, including- 1. Provide bulk to the formulation. 2. Aid in handling of “API” during manufacturing. 3. Ease of administration to the target patient population(s) by the intended route. 4. Improved dosing compliance (to give a particular shape and to improve palatability, elegance of the formulation). 5. Facilitate drug absorption or solubility and other pharmacokinetic considerations. 6. Modulating solubility & bioavailability of APIs. 7. Consistency and control of drug bioavailability. 8. To enable bioavailability. 9. Improved API stability in dosage forms including protection from degradation/ denaturation. 10. To ensure a robust and reproducible physical product. 11. Helping active ingredients maintains preferred polymorphic forms or conformations, 12. Maintaining the pH and /or osmolarity of the liquid formulations, 13. Preventing aggregation or dissociation (e.g. of protein and polysaccharide actives). 14. Modulating immunogenic responses of active ingredients (e.g. adjuvants), and more. N.B: Excipients, in certain cases, interacts with the active ingredient in the final formulated dosage form or may provide a matrix that affects the critical quality attributes of the active ingredients like stability and bioavailability. Q. Classify excipients. There are various types of excipients available in pharmaceutical formulation. They are, 1. Diluents. (Fillers/ bulking agents) 2. Binders. 3. Disintegrating agents. 4. Granulating agents. 5. Lubricants. 6. Glidants. 7. Preservatives. 8. Antioxidant. 9. Flavouring agents. 10. Sweeting agents. 11. Colouring agents. 12. Ointment base. 13. Solvent & Co-solvent. 14. Buffering Agents. 15. Chelating Agents. 16. Viscosity imparting Agents. 17. Surface Active Agents/ Surfactants. 18. Coating agents. 19. Sorbents. 20. Humectants. Q. Write down the fundamental characteristic of pharmaceutical excipients. Properties of an ideal excipient: 1. It should be feasible. 2. It should be nontoxic, nonirritant. 3. It should be nonvolatile. 4. It should be stable itself and not affected by temperature, light and hydrolysis. 5. It should be readily available and cheap. 6. It should be colourless, odourless and tasteless. 7. It should be soluble in water as well as oil and fat. 8. It should be compatible with the active ingredient in the preparation. 9. It should have no interaction with the API. 10. It should be pharmacologically inert in the formulation. Pharmaceutical Excipients
  • 2. Shamiul Bashar 1st Batch B. Pharm, VU 2 Pharmaceutical Excipients Q. Write down the innovation in pharmaceutical excipients. Innovation in pharmaceutical excipients: In general, there are three types of new excipients and the development process of these varies significantly:  Modified Excipients: Well known excipients with established quality standards can be modified with regard to their impurity profile or their physical properties. The development for modified excipients time is relatively short with a low R&D investment and a low associated risk.  Co-Processed Excipients: Two or more excipients are formulated without chemical changes in order to achieve new performance characteristics which cannot be achieved by simple physical mixing. The development of a co-processed excipient is more complex.  Novel Excipients: It is used for the first time in a drug product or a new route of administration. Novel excipient’s development is substantially similar to the non-clinical development of a new active ingredient: A high R&D investment and a long development time. As a consequence, only very few manufacturers are willing to invest in the development of a novel excipient. Product development of new excipients has three main goals:  To demonstrate the advantage over existing materials for the target application.  To establish a reliable manufacturing process that leads to the desired product characteristics.  To demonstrate the appropriate stability of the new grade. Q. Elucidate the different functional roles of excipients in different formulation. The excipients, ingredients other than the active pharmaceutical ingredient, in a dosage form have different functionalities, depending on how they are used in a formulation or the type of formulation they are incorporated into. For a more in-depth discussion addressing dosage form development and manufacturing concerns around excipient choice and use. Certain excipients can have different functional roles in different formulation types, e.g. lactose; widely used as: • A diluent, filler or bulking agent in tablets and capsules • A carrier for dry powder inhalation products (DPIs). Furthermore, individual excipients can have different grades, types and sources depending on those different functional roles. For example, there are various grades of lactose commercially available that have different physical properties, e.g. flow characteristics & particle size distributions. This permits selection of the most suitable grade for a particular need. • Wet Granulation: usually, finer grades of lactose are used so that the binder is more efficient and this permits better mixing and granule quality. • Direct Compression: in contrast here, spray dried lactose is used as it has good flow properties and is more compressible. • For dry powder inhalers: crash-crystallisation fine-milled lactose with a coarser fraction for flow and a finer fraction to enhance API aerosolisation and delivery to the lungs.
  • 3. Shamiul Bashar 1st Batch B. Pharm, VU 3 Pharmaceutical Excipients Q. Define stability of pharmaceutical preparation and stabilizer. Classify it. Stability: Stability of pharmaceutical product may be defined as the capability of a particular formulation in a specific container closure to remain within the physical, chemical, microbiological, therapeutic and toxicological specifications. Stabilizers: The substances which are used to control these stabilities are known as stabilizers. The most important stabilizers are, 1. Antioxidants and 2. Preservatives. Diluents/ Fillers Fillers typically also fill out the size of a tablet or capsule, making it practical to produce and convenient for the consumer to use. e.g., Minimum tablet weight is typically ~50mg. Actual API doses can be as low as ~20μg, e.g. for oral steroids. When the quantity of a drug for an individual dose is very small then it is practically impossible to compress then the inert substances which are added to increase the bulk for easy compression a known as diluents. Diluent’s are filler used to make required bulk of tablet when the dosage itself is inadequate to produce this bulk. Secondary reason is to provide better tablet properties such improved cohesion, to permit use of direct compression manufacturing, or to promote flow. Function of fillers:  Bulking agent: Fillers add volume and/or mass to a drug substance, thereby facilitating precise metering and handling thereof in the preparation of dosage forms . Used in tablets and capsules.  Compression aid: Deforms and/or fragments readily to facilitate robust bonding in tablet compacts, e.g. microcrystalline cellulose.  Good bulk powder flow diluents have a strong influence: Good flow of bulk powders is very important in designing a robust commercial tablet product. Typical features of fillers: An ideal diluent should have the following criteria- 1. They should typically be inert and non-toxic. 2. They should be preferably tasteless or pleasant tasting. 3. They must be compatible with the other components of the formulation. 4. They must be physically and chemically stable. 5. They must be non-hygroscopic. 6. They must be free from any unacceptable microbiologic load. 7. They must be commercially available is all acceptable grade. 8. They do not alter bioavailability of the drug. 9. They must be color compatible. Examples: Plant cellulose and dibasic calcium phosphate are used popularly as fillers. A range of vegetable fats and oils can be used in soft gelatin capsules. Other examples of fillers include: lactose, sucrose, glucose, mannitol, sorbitol, calcium carbonate, calcium sulfate, magnesium stearate, Microcrystalline cellulose (MCC), Powdered cellulose, Dextrates, Dextrin, Dextrose, Kaolin, Maltodextrin, Starch, Sucrose Favoured combinations: Lactose is an excellent choice of filler in many respects but can exhibit poor flow characteristics, so is often combined with free-flowing microcrystalline cellulose in wet granulation formulations.
  • 4. Shamiul Bashar 1st Batch B. Pharm, VU 4 Pharmaceutical Excipients Binders Binders hold the ingredients in a tablet together. Binders ensure that tablets and granules can be formed by increasing cohesive state of the drug powder, with required mechanical strength. In other word according to WHO binders act as an adhesive to ‘bind together’ powders, granules and tablets to result in the necessary mechanical strength: • As a dry powder with other excipients in dry granulation (roller compaction, slugging) or as an extra-granular excipient in a wet granulation tablet formulation. • As a dry powder with other intra-granular excipients in wet granulation. When the granulating fluid is added, the binder may dissolve partially or completely to then exhibit adhesive binding properties in helping granules to form. • Most commonly in wet granulation, the binder is added already dissolved in the granulating fluid to enable a more effective and controllable granule formation. • Water is the most common granulating fluid, very occasionally in a co-solvent system with, e.g. ethanol. Typical features of binders: A binder should be compatible with other products of formulation and add sufficient cohesion to the powders. Classification and examples: Binders are classified according to their application,  Dry binders are added to the powder blend, either after a wet granulation step, or as part of a direct powder compression (DC) formula. e.g., Pregelatinised starch, cross-linked PVP, cellulose, methyl cellulose, and polyethylene glycol.  Solution binders are dissolved in a solvent (for example water or alcohol can be used in wet granulation processes). e.g., PVP, HPMC, gelatin, cellulose, cellulose derivatives, starch, sucrose and polyethylene glycol.  Soluble in water/ethanol mix: PVP Acacia, Tragacanth, Gelatin, Sucrose, Starch paste are soluble in water and are not used in water sensitive drugs, while Na-alginate, Methyl cellulose dissolved in alcohol and PVP, Methyl cellulose drugs, while Na-alginate, Hydroxy Propyl cellulose dissolved both water and alcohol. In case of water sensitive drugs first bender need to dissolve on alcohol and then other excipients and active ingredients are mixed with it. Other example of binders include Alginic Acid, Sodium alginate, Carboxymethyl cellulose sodium (CMC), Microcrystalline cellulose (MCC), Powdered cellulose, Confectioner’s sugar, Dextrin, Dextrose, Ethylcellulose, Guar gum, Hydroxypropyl cellulose (HPC), Hypromellose (HPMC), Lactose, Maltodextrin, Methylcellulose, Povidone, Zein. Table: Some binders their concentration and required solvent are given below. Binders Used concentration Required solvent 1. Acacia 2-5% H2O 2. Tragacanth 1-3% H2O 3. Sucrose 2-20% H2O 4. Gelatin 1-4% H2O 5. Starch past 1-4% H2O 6. Na-alginate 3-5% Alcohol 7. Methyl cellulose 1-4% Alcohol 8. Pyrrolidone 2-5% H2O and Alcohol 9. Ethyl celluese 0.2-0.5% H2O and Alcohol
  • 5. Shamiul Bashar 1st Batch B. Pharm, VU 5 Pharmaceutical Excipients Disintegrants Disintegrants are substances or mixture of substances added to the drug formulations, which facilitate dispersion or breakup (disintegration) of tablets and contents of capsules into smaller particles for quick dissolution when it comes in contact with water in the GIT. They are mainly two types- a. Substances which hydrate and swell up in contact with water. b. Substances which react with effervescent when they come in contact with moisture for example combination of Na-CO3, citric acid and tartaric acid. Ideal properties of disintigrants: Good hydration capacity , poor solubility , poor gel formation capacity. Mode of action: • In many cases water uptake alone will cause disintegration, by rupturing the intra-particle cohesive forces that hold the tablet together and resulting in subsequent disintegration. • If swelling occurs simultaneously with water uptake, the channels for penetration are widened by physical rupture and the penetration rate of water into the dosage form increased. Examples: PVP, CMC, Sodium starch glycolate, Alginic Acid, Sodium alginate, Microcrystalline cellulose (MCC), Croscarmellose sodium, Crospovidone, Guar gum, Polyacrilin Potassium, Sodium Starch Glycolate, Veegum HV, bentonite 10% and cellulose derivatives Ac-Di-Sol(Na-CMC), Alginate. Q. Why are disintegrates added in two fractions for the formulation of tablet dosage form? During manufacturing the tablets disintegrating agents are added in two steps- a. Major par is incorporated to the powder before granulation. b. Other part is mixed with the dried granulation along with lubricants before compression. Disintegrates are added in a manner to serve two purposes- a. The disintegrates added after granulation breaks the tablet apart into granules b. The portion added before granulation convert granules into fine particles thus facilitating tablet dissolution. The disintegrating time depend on- 1. Quality of diluent, binder, lubricant 2. Hardness of tablet 3. Size of granules 4. And finally on coating. Super disintegrates: These disintegrates which swells up to 10 to fold within 30 seconds when they water. Significant improvement in disintegrant performance was achieved with the introduction of the first super disintegrant. For example- Cross carmellose-cross linked cellulose Cross providone- cross linked providone Sodium starch glycolate-cross linked starch. Evaluation of CO2 on effervescent tablet is one of the ways of disintegration.
  • 6. Shamiul Bashar 1st Batch B. Pharm, VU 6 Pharmaceutical Excipients Granulating Agents Granulating agents are the substances which are added to powders during granulating process to convert fine powders into granules. Insufficient quantity of granulating agent may lead to poor adhesion, soft tablets and capping, where as excessive quantity may lead to hard tablets into grater disintegration time. Example: Commonly used granulating agents are- water, mucillages of acacia, tragacanth, Copolyvidone, sucrose and starch. Liquid glucose syrup and alcohol in various dilutions. Alcohols are used for water sensitive drug. Antiadherents, Lubricants & Glidants Antiadherents: Antiaderents or anti-sticking agents prevent adhesion of the tablet surface to the die walls and the punches and as a consequence counter the picking or sticking of tablet. Examples of Antiadherents: Water insoluble lubricants such as magnesium stearate can be used as antiadherents , as can talc and starch. Lubricants: Lubricants prevent ingredients from clumping together and from sticking to the tablet punches or capsule filling machine. Lubricants also ensure that tablet formation and ejection can occur with low friction between the solid and die wall. Types: 1. Hydrophilic- Generally poor lubricants, no glidant or anti-adherent properties. 2. Hydrophobic- Most widely used lubricants in use today are of the hydrophobic category. Hydrophobic lubricants are generally good lubricants and are usually effective at relatively low concentrations. Many also have both anti- adherent and glidant properties. For these reasons, hydrophobic lubricants are used much more frequently than hydrophilic compounds. Examples include magnesium stearate. Roles of lubricants: 1. True Lubricant Role: • To decrease friction at the interface between a tablet’s surface and the die wall during ejection and reduce wear on punches & dies. 2. Anti-adherent Role: • Prevent sticking to punch faces or in the case of encapsulation, lubricants • Prevent sticking to machine dosators, tamping pins, etc. 3. Glidant Role: • Enhance product flow by reducing interparticulate friction Examples of lubricants: Polyethylene glycol, Stearic acid, Magnesium stearate, Calcium stearate, Glyceryl monostearate, Isopropyl Myristate, Polyvinyl Alcohol, Sodium Stearyl Fumarate, Talc Glidants: A substance (as colloidal silica) that enhances the flow of a granular mixture by reducing inter-particle friction and that is used in the pharmaceutical production of tablets and capsule. Functions of glidants: Glidants are used to promote powder flow by reducing interparticle friction and cohesion. These are used in combination with lubricants as they have no ability to reduce die wall friction. Examples of Glidants: Fumed silica, Colloidal silicon dioxide, talc, syloid, aerosil and magnesium carbonate.
  • 7. Shamiul Bashar 1st Batch B. Pharm, VU 7 Pharmaceutical Excipients Table: Different between glidant and lubricant Glidant Lubricant 1. It improves the flow ability of the powder. 1. It ensures tablet formulation and ejection with low fraction. 2. The glidant is often added to a granulation before tableting. 2. Lubricant gives action after tableting. 3. They adhere particle surface of the other ingredients and improve flow. 3. They adhere to the die wall. 4. They reduce the interparticulate friction. 4. Reduce friction between solid and die cavity. 5. Usually glidant are solid. 5. Lubricant may be liquid. 6. e.g. Silica, Magnesium carbonate, talc, syloid, aerosil etc. 6. e.g. Stearic acid, Magnesium stearate, Calcium stearate, polyethylene glycol etc. Preservatives Preservatives are substances that commonly added to various foods and pharmaceutical products to prevent or inhibit the growth of microorganisms in the preparations in order to prolong their shelf life. Some preservatives, either by concentration or activity, may only maintain the bacteria level in the product at the time of manufacture and are referred to as bacteriostatic preservatives. Ideal properties of preservatives: In concept, the preservative system protects the product against microbial proliferation but does not compromise product performance. In practice, this means that it must: 1. Exert a wide spectrum of antimicrobial activity at low inclusion levels. 2. Maintain activity throughout product manufacture, shelf life and usage. 3. Not compromise the quality or performance of product, pack or delivery system. 4. Not adversely affect patient safety or tolerance of the product. 5. It should be effective against a wide range of microorganisms such as bacteria, mold and fungi etc at room temperature. 6. It should be chemically compatible with other ingredients of the formulation. 7. It should be nontoxic and non-sensitizing. 8. It should be soluble in aqueous phase when used in emulsions. 9. If the system is biphasic, the partition-coefficient should be in favor of the aqueous phase. 10. It should be effective at low concentration. 11. It should be nontoxic, nonirritant. 12. It should be odourless, tasteless, and should not impart colour in the formulation. 13. It should be stable and effective over a wide range of pH. 14. It should be neutral and should not react chemically with other constituent. 15. It should be of low volatility to ensure that loss does not occur during storage. 16. It should be thermostable 17. It should preserve the preparations and remain stable for the shelf life of the product. Examples: Methylparaen, Ethyl parabens, Propylparaben, Butylparaben, Benzoic acid and its salts, Sorbic acid , Potassium Sorbate. Alcohol, Benzalkonium chloride, Boric acid, Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Phenol, Phenethyl Alcohol, , Propylene Glycol.
  • 8. Shamiul Bashar 1st Batch B. Pharm, VU 8 Pharmaceutical Excipients Q. Define combine preservative. Why more than one preservative are used in pharmaceutical formulation. Combine preservatives: The use of two or more preservative collectively known as combine preservative. No single preservative possesses all the ideal properties. Sometime a single preservative in not enough or not have the ability to kill or inhibit the growth of microorganism. Therefore it becomes necessary to use a combination of preservatives to prevent the growth of microorganisms. Then two or more preservatives are used to increase their preservatives action. In combine preservatives, have a broad spectrum of microbial qualities. e.g., 0.1- 0.2% methyl paraben and propyl paraben which are oil and water soluble respectively used due to their synergist effect in combined form. Q. How you will evaluate preservatives? Problems of selection of preservatives. Evaluation of preservatives: 1. To assess the number of viable number or microbes in the final product as in function of time. 2. To assess the quantities of preservatives compound at specific interval of time. Problems of selection of preservatives: 1. The problem of selection of preservatives for emulsion systems is unique. 2. It is desirable to have a compound which distributes to a large extent in the aqueous phase. At the same time the preservatives compound must have a tendency to get concentrated in the lipids of microbial cell in preference to remaining in the aqueous phase. Q. Write on about benzoic acid & benzoate, parahydroxybenzoates, phenyl mercuric nitrate & other salt, phenol, dichlorophen, formaldehyde. Benzoic acid and benzoates 1. Simple aromatic acid. 2. Use as a preservative for food, drug, cosmetics etc. 3. Concentration 0.1%. Salicylic acid and salicylates Use as sodium salicylate for enfant of 1 part to 1000. Parahydroxybenzoates 1. Use for the preservation of food and drug. 2. Various ester of p-hydroxy benzoic acid having methyl, ethyl propyl and butyl radicals are marketed by different forms under names such as Nipase ceries paraben etc. 3. Concentration 0.005-0.05% 4. Powerful preservative. 5. The esters are considered to be 2-3 times effective as benzoic acid. 6. The different ester may have different action against different classes of microbes. For instance, a methyl ester is considered to be more effective against mould. Propyl ester is so against yeasts. Phenyl mercuric nitrate & other salt 1. Low concentration as 1 in 1,00,000. 2. Use for cosmetic. 3. It is recognized preservatives of pharmaceutical product for parental use.
  • 9. Shamiul Bashar 1st Batch B. Pharm, VU 9 Pharmaceutical Excipients Phenol 1. Classical germicide. 2. Use in lotion and other preparation for internal use. 3. Used in particular products packed as multiple doses in concentration of 0.5% Dichlorophen 1. Fungicide and bactericide. 2. Use for preservation of natural fiber like cotton and wool. 3. Use as an ingredient for hair tonic and athletes. 4. It is rather tonic and not use in pharmaceutical preparation as preservatives. Formaldehyde 1. Good preservatives for different kind of material. 2. It is not use in pharmaceutical preparation as preservatives. 3. Is has strong pungent and irritant properties. Antioxidant Antioxidant: An antioxidant is a substance which is added to pharmaceutical formulation to prevent the oxidative degradation of the drug in the presence of oxygen or peroxides. They act by blocking an oxidative chain reaction. The antioxidants have great affinity for oxygen and when they are added to formulation they compete for its affording protection to other oxygen sensitive drug. Function of anti-oxidant: Used to control oxidation of-  API  Preservative, e.g. potassium sorbate  Vehicle, e.g. oils or fats susceptible to β-oxidation (rancidification)  Colourants (ageing discolouration) Some antioxidants are: 1. Quinol group:  Hydroquinone  Tocopherols  Hydroxychromans 2. Catechol group:  Catechol  Pyrogallol  Gallic Acid  Ethyl Gallate 3. Nitrogen containing Substance:  Alkanolamine  Diphenylamines  Casein  Edestine 4. Sulphur containg Substance:  Cysteine Hydrochloride 5. Monohydric Phenol:  Thymol Concentration of antioxidant in formulation: 0.001 – 0.1% Classification of antioxidant: 1. On the basis of the function antioxidants are 2 types. They are, a. Primary antioxidant/ true antioxidant. b. Synergist. a. Primary antioxidant: Primary antioxidants act by interfering with the propagation step of autoxidaton process. e.g., Tocopherol (Vitamin E), Gallic acid, Butylated hydroxyl anisol (BHA), Butylated hydroxyl tolune (BHT) and nordihydroguaiaretic acid (NDGA).
  • 10. Shamiul Bashar 1st Batch B. Pharm, VU 10 Pharmaceutical Excipients b. Synergist: The synergist class of antioxidants has little inherent antioxidal properties. However, when used in conjugation with a primary antioxidant they have the ability greatly to enhance antioxidant efficiency. e.g., 1. Water Soluble:  Citric Acid  Tartaric Acid  Phosphoric Acid  Ascorbic Acid (having antioxidant property) 2. Oil Soluble:  Ascorbyl Palmitate  Mono-isopropyl Citrate  Palmityl Phosphate  Mono-stearyl Citrate 2. On the basis of the source antioxidants are 2 types. They are, a. Natural antioxidants. b. Synergist antioxidant. a. Natural antioxidant: These exist and available in nature. e.g., Tocopherol (Vitamin E), Sesamol, Guaiac resin, Mehionine. b. Synthetic antioxidant: These are isolated by synthesis by an artificial mean. i.e Butylated hydroxyl anisol (BHA), Butylated hydroxyl tolune (BHT), Tertiary butyl hydroquinone. 3. On the basis of solubility antioxidants are 2 types. They are, a. Water soluble antioxidant. b. Oil soluble antioxidant. a. Water soluble antioxidant: The main classes of water soluble antioxidants are sulfurous acid salt, ascorbic acid isomers and thhiol derivatives. Compound Drug for which suitable Sodium Metabisulfite 1. Steroids. 2. Antibiotics. 3. Adrenergic. 4. Procainaonid. 5. Morphine. b. Oil soluble antioxidant: The oil soluble antioxidants are often needed for the protection of fatly food and osmotic. Compound Material for which suitable BHA and BHT Fatty formulation. Properties of Antioxidants: 1. An ideal antioxidant should be stable. 2. Effective at a low, nontoxic concentration. 3. It should not posses objectionable color, odor and taste. 4. It should be nontoxic, nonirritant and form no harmful products. 5. It should be thermostable. 6. It should be readily soluble or dispersible in the medium. 7. Soluble at the required concentration. 8. It should be compatible with formulation ingredients and packaging material. 9. Stable and effective under normal conditions of use, over a wide pH and temperature range. 10. Compatible with a wide variety of drugs and pharmaceutical excipients. 11. It should be neutral and should not react chemically with other constituents present. 12. Colorless in both the original and oxidized form. 13. Nontoxic both internally and externally at the required concentration. 14. Reasonable cost. 15. Unreactive (does not adsorb, penetrate, or interact) with containers or closures.
  • 11. Shamiul Bashar 1st Batch B. Pharm, VU 11 Pharmaceutical Excipients Mode of action: Anti-oxidants act by- 1. By acting as a reducing agent. 2. By acting as free radical inhibitor to block the oxidative chain reaction. 3. By acting as synergist increasing the efficiency of antioxidant. 4. By acting a chelating agent such as EDTA salt. This salt complex with metal ion which catalyze the oxidative reaction. Q. Define oxidation, auto-oxidation, and pre-oxidants. Oxidation: Oxidation is defined as loss of electrons or addition of oxygen. Auto-oxidation: It is a reaction with oxygen of air which occurs spontaneously without other factors. Pre-oxidants: These are substances catalyze oxidation process e.g., metals, some impurities. Q. Write down the chemical groups which undergo oxidation. Chemical groups which undergo oxidation: 1. Phenolic compounds: Phenylephrine. 2. Catechol derivatives: Adrenaline and noradrenaline. 3. Some antibiotics: Tetracyclines. 4. Oils (fixed and volatile). 5. Vitamins (lipid and water soluble). Q. How to evaluate oxidation in pharmaceutical agent form? By monitoring the following objective we can identify oxidation. 1. Change of color, odor, and viscosity of screening/ pharmaceutical agents. 2. For fixed and volatile oils: change of color, taste, odor, and viscosity Q. How you can protect pharmaceutical from oxidation? Protection of drugs from oxidation: 1. Addition of Antioxidants: Vitamin E, vitamin C and inorganic sulfur compounds, thiosulfate and polysulfide. 2. Addition of chemicals which form complexes with metals e.g., EDTA, Benzalkonium chloride 3. Protection from light: a. Using of dark container. b. Storage in dark places. c. Packaging with substances which absorbed light e.g., Oxybenzene. 4. Choice of suitable pharmaceutical dosage forms which reduce the possibility of oxidation process (solid dosage forms are better than solutions). 5. Maintenance of pH by using buffer solution. 6. Choice of suitable solvent (rather than water). 7. Storage in low temperature. 8. Protection from air by: a. Using good closed containers. b. Replacement of oxygen by nitrogen.
  • 12. Shamiul Bashar 1st Batch B. Pharm, VU 12 Pharmaceutical Excipients Q. Mention commonly used drugs sensitive to oxidation. Drugs that are sensitive to oxidation are, 1. Ascorbic acid (Vitamin C) 2. Chlorpromazine. 3. Cyanocobalamine (Vitamin B12) 4. Gentamicin. 5. Heparin. 6. Hydrocortisone. 7. Resorcinol. 8. Riboflavin (Vitamin E) 9. Streptomycine. 10. Methyldopa. 11. Morphine. 12. Penicillin. 13. Tetracycline. 14. Thiamine (Vitamin B1) 15. Vitamin A,D and E 16. Paracetamol Sweetening agents Sweetening agents are employed in liquid formulations designed for oral administration specifically to increase the palatability of the therapeutic agent. Example: Sucrouse, Lactose, Saccarine, Aspertame, Sorbitol, Mannitol etc. Uses of sweetening agent:  The main sweetening agents employed in oral preparations are sucrose, liquid glucose, glycerol, sorbitol, saccharin sodium and aspartame. Aspartame is an artificial sweetening agent. The use of artificial sweetening agents in formulations is increasing.  In anthelmintic and multivitamin tablets sweeting agents are used.  The use of sugars in oral formulations for children and patients with diabetes mellitus is to be avoided. Why mannitol is extensively used in chewable tablets: Chewable tablets are intended to be chewed in the mouth prior to swallowing and are not intended to be swallowed intact. The use of sweeteners is primarily limited to the chewable tablets to exclude or limit the use of sugar in the tablet. Sucrose causes hyperglycaemia. So we have to exclude it in the chewable tablet. Saccharine can use in place of sucrose, but it has the disadvantage that it has a bitter after taste and has been reported to be carcinogenic. Aspartame can be used in place of saccharine, but the primary disadvantage of aspartame is its lack of stability in the presence of moisture. For the above reason mannitol is used extensively in the chewable tablet because- a. Mannitol is reportedly about 72% as sweet as sucrose. b. It does not have bitter after taste. c. It has the stability in the presence of moisture. d. It does not produce hyperglycaemia. Flavoring Agents Flavouring agents are the substances which are used to impart pleasant, smell to the preparation and to mask specific type of taste of the preparation, thus make them more palatable and improve patient acceptance. The four basic taste sensations are salty, sweet, bitter and sour. It has been proposed that certain flavours should be used to mask these specific taste sensations. Example: Clove oil, citric and syrup, glycerin, rose oil, orange oil, raspberry flavor, vanilla flavor etc.
  • 13. Shamiul Bashar 1st Batch B. Pharm, VU 13 Pharmaceutical Excipients Classification flavouring agents: 1. Natural flavouring agent: The flavouring agents obtained from natural sources include pine- apple, banana, cardamom, ginger, cinnamom, peppermint and volatile oils obtained from anise, caraway clove, dill, lemon oil, orange, rose, jasmine, lavender etc. Malt extract. glycyrrhizin extract, coffee, vanilla, chocolate and tolu balsam are also used as flavouring agents. Menthol, mannitol, chloroform spirit and chloroform water are widely used as flavouring agents in liquid formulations. 2. Synthetic colouring agent: Synthetic chemical like certain alcohol, aldehydes, esters, fatly acids, ketones and lactones are used as flavouring agents. More recent butterscotch, ‘tutti- frutti’ flavor are used. Q. Why synthetic flavouring agents are better than natural flavouring agents. Most of the flavours used in pharmaceutical preparations are obtained from natural sources but now a days they are being replaced by synthetic flavours. This is due to, 1. They are constant in composition. 2. They are readily available. 3. They are comparatively cheap. 4. They are more stable. 5. Their incompatibilities are more predictable. Coloring and Opacifying Agent Coloring agents are pharmaceutical ingredients that impart the preferred color to the formulation. The function of these ingredients is to enhance the product quality. They provide- 1. Product identification. 2. Protect the core from light and moisture. 3. They increase the solid concentration with any impact on viscosity thus reducing the drying time. They are either soluble or form fine suspension in the solvent system. For uniform distribution the particle size must be < 10 microns. If a very light shade is desired a concentration is less than 0.01%. On the other hand if dark color is required concentration is more than 2%. Example: White: Titanium dioxide Blue : Brilliant blue ,Indigo carmine Red : Amaranth Carmine Yellow: saffron Green Brown: caramel Dyes are soluble forms of a particular color. They go into solution and can result in very deep, vibrant colors and therefore used in liquid products. The most common colorants used are FD&C or D&C certified, these are either dyes or lakes of dyes. FDC red-2 Amaranth FDC green -3 Green FDC green -4 Erithrosine FDC yellow-5&6 Tartrasine FDC blue-1 Brilliant blue FDC blue-2 Indigo Lakes are dyes that undergo a processing step that adheres them onto insoluble substrates. Since lake contain less colorant so required in larger concentration in solution. Lakes are used in chewable products and coating solutions for tablets. e.g., aluminum or calcium salts, iron oxide, anthrocyanins, caramel, carotenoids, chlorophyll, indigo, flavones, turmeric acid and carminic acid. Opacifiers are used to give more pastel color and increase film coverage. These can provide white coat or mask the color of the tablet core. These are mostly inorganic material. The substances employed are- Titanium dioxide (Most Common), Talc, Aluminum silicate, Magnesium carbonate, Calcium sulfate, Aluminum hydroxide
  • 14. Shamiul Bashar 1st Batch B. Pharm, VU 14 Pharmaceutical Excipients Ointment Bases Q. Define ointment bases and mention its ideal properties. Ointment Bases: The ointment base is that substance or part of an ointment which serves as a carrier or vehicle for the medicament. Properties of an ideal ointment base: 1. It should be inert. 2. It should be stable. 3. It should be smooth. 4. It should be compatible with the skin. 5. It should be non-toxic and non-irritating. 6. It should be nonvolatile. 7. It should have low melting point. 8. It should release the incorporated medicament readily. Since there is no single ointment base available which possesses all these qualities, therefore it becomes necessary to use more than one ointment base in the preparation of ointments. Q. Classify ointment base. The ointment bases are classified as follows: 1. Oleaginous bases 2. Absorption bases 3. Emulsion bases 4. Water soluble bases. Q. Describe oleaginous base with its disadvantage Oleaginous Bases: These bases consist of water insoluble hydrophobic oils and fats. The most important are the hydrocarbons. i.e. mineral oil, petrolatums and paraffins. The animal fat includes lard. The combination of these materials can produce a product having desired melting point and viscosity. The oleaginous bases are decreasing in favour due to the reasons described 1. They are greasy. 2. They are difficult to remove both from skin and clothings. 3. The release of medicament is not certain. 4. If some animal fat is included it may get rancid. 5. Fatty mixture bases prevent drainage on oozing areas and also prevent evaporation of cutaneous secretions including perspiration. The water retention increases the heat in the particular areas. Q. Briefly describe hydrocarbon bases. Hydrocarbon Bases 1. Petrolatum (Soft Paraffin): It is a purified mixture of semisolid hydrocarbons obtained from petroleum. There are two varieties of soft paraffin, one is yellow soft paraffin and the other is white soft paraffin. Yellow soft paraffin is a pale yellow to yellow translucent soft mass, free or almost free from odour and taste. It has a melting point of 38°C to 56°C. White soft paraffin is obtained by bleaching yellow soft paraffin. It is a white translucent tasteless mass and is odourless when rubbed on the skin. It has a melting point of 38°C to 56°C. White soft paraffin is used when the medicament is while or colourless. Both yellow and white soft paraffins are used and have no noticeable action on the skin and are not absorbed. Thus they are suitable for epidermal type of preparations. Because of hydrophobic nature, aqueous liquids cannot be mixed with it but sometimes wool fat and waxes are included to incorporate aqueous liquids in it.
  • 15. Shamiul Bashar 1st Batch B. Pharm, VU 15 Pharmaceutical Excipients 2. Hard Paraffin: It is a purified mixture of solid hydrocarbons obtained by distillation from petroleum or shale oil. It is a colourless or white translucent, odourless, tasteless mass and is used to harden or stiffen the ointment bases. 3. Liquid Paraffin: It is also known as liquid petrolatum or white mineral oil. It consists of a mixture of liquid hydrocarbons and may be obtained from petroleum by distillation. Liquid paraffin varies in composition according to the source of the petroleum. It is a colourless, transparent, tasteless and odourless oily liquid. It is insoluble in water and alcohol but soluble in ether and chloroform. It is used along with hard paraffin and soft paraffin to get a desired consistency of the ointment. It is also used to levigate the substances insoluble in it. Q. Briefly describe absorption base. Give its advantage and disadvantage. Absorption Bases: The term absorption is used to denote the hydrophilic characters of the base. These are generally anhydrous bases which can absorb a large amount of water but still retain their ointment like consistency. The following are some of the absorption bases used. 1. Wool Fat: a. It is also known as anhydrous lanolin. b. It is the purified anhydrous fat like substance obtained from the wool of sheep. c. It is practically insoluble in water but can absorb about 50% of its weight of water. d. Due to its sticky nature it is not used alone but is used along with other bases in the preparation of a number of ointments. 2. Hydrous Wool Fat: a. It is also known as lanolin. b. It is the purified fat like substance obtained from wool of sheep. c. It is a yellowish white ointment like mass with characteristic odour. d. It is insoluble in water but soluble in ether and chloroform. 3. Wool Alcohol: a. It is obtained from wool fat by treating it with alkali and separating the fraction containing cholesterol and other alcohols. b. It contains not less than 30% of cholesterol. c. It is used as an emulsifying agent for the preparation of water in oil emulsions and is used to absorb water in ointment bases. d. It is also used to improve the texture, stability and emollient properties of oil in water emulsions. 4. Bees Wax: a. It is purified wax obtained from the honeycomb of bees. b. It is of two types: (a) yellow bees wax and (b) white bees wax obtained by bleaching and purifying the yellow bees wax. c. Bees wax is used as a stiffening agent in pastes, ointments and other preparations. 5. Cholesterol: a. It is widely distributed in animal organisms. b. Wool fat is also used as a source of cholesterol. It is used to increase the incorporation of aqueous substances in oils and fats. Advantages of Absorption Bases 1. They are compatible with majority of medicaments. 2. They are relatively heat stable. 3. These bases may be used in their anhydrous form or in emulsified form. 4. They can absorb a large quantity of water or aqueous substances. 5. They can be more easily removed from the skin in compared to the oily bases. Disadvantages of Absorption Bases 1. These bases possess the undesirable property of greasiness.
  • 16. Shamiul Bashar 1st Batch B. Pharm, VU 16 Pharmaceutical Excipients Q. Write a short note on i. Emulsion and ii. Water absorption base. i. Emulsion Bases: Emulsion bases are semi solid emulsions having cream like consistency. These are of two types: oil in water or water in oil emulsions. Some additional amount of water can be incorporated in both the types and still retain soft cream like consistency. The oil in water type emulsion bases are more popular because they can be easily removed from the skin or clothings by washing with water. The water in oil emulsion bases are greasy and sticky, therefore they are difficult to remove from the body and clothings. Examples of emulsion bases include hydrophilic ointment, rose water ointment and vanishing creams. ii. Water Soluble Bases: Water soluble bases contain only the water soluble ingredients and not the fats or other greasy substances that is why sometimes they are known as greaseless bases. They differ from emulsion bases that the latter contain water soluble and water insoluble components. Since these bases do not contain ally fats or oils, they can be easily washed with water from the skin and clothings. Certain other substances which are used as water soluble bases include tragacanth, gelatin, pectin, silica gel, sodium alginate, cellulose derivatives, magnesiutn-aluminium silicate and bentonite. In the true sense these substances are not water soluble but they swell up with the absorption of water. Q. Define carbowaxes wits its ideal properties. Carbowaxes: Water soluble bases consist of water soluble ingredients such as polyethylene glycol polymers which are popularly known as carbowaxes. Ideal properties of Carbowaxes: 1. Carbowaxes are water soluble. 2. They are non-volatile. 3. They are inert substances. 4. They do not hydrolyse and do not support the bacterial or mold growth. 5. The release of medicament is rapid. 6. A blend of different carbowaxes is used to get an ointment of desired consistency. Q. Mention the factor governing selection of an ideal ointment base. Factors Governing Selection of an Ideal Ointment Base: The factors which may help in the selection of an ideal ointment base are discussed below: 1. Dermatological factors. 2. Pharmaceutical factors. 1. Dermatological Factors a. Absorption and Penetration: The word 'absorption' means actual entry into the blood stream, i.e. systemic absorption whereas 'penetration' means transference through the skin, i.e, cutaneous penetration. Various experiments have been conducted by a number of scientists to study the problems of absorption and penetration which may be summarized as follows: i. Only the ointment base penetrates deep into the tissues of the skin. ii. It is mainly medicament which is absorbed into the blood stream. iii. Paraffins do not readily penetrate the skin whereas animal and vegetable fats and oils normally penetrate the skin. Animal fats, e.g. lard and wool fat when combined with water, penetrates the skin. iv. Substances which are soluble both in oil and water are most readily absorbed. v. Water soluble substances are more readily absorbed from water soluble bases. vi. O/W emulsion bases release the medicament more readily than greasy bases or W/O emulsion bases.
  • 17. Shamiul Bashar 1st Batch B. Pharm, VU 17 Pharmaceutical Excipients b. Effect on Skin Function: Greasy bases interfere with normal skin functions, i.e. heat radiation and sweat. 'They are irritant to the skin. O/W emulsion bases and other water miscible bases produce a cooling effect rather than heating effect and mix readily with skin secretions. c. Miscibility with Skin Secretions and Serum: Skin secretions are more readily miscible with emulsion bases than with greasy bases. Due to this miscibility the drug is more rapidly and completely released to the skin hence lesser proportion of the medicament rs required when such bases are used. O/W emulsion bases are more readily miscible with serum from broken skin therefore they are particularly useful in weeping eczema. d. Compatibility with Skin Secretions: The bases used should be compatible with skin secretions and should have a pH about 5.5 because the average pH of the skin secretions is around 5.5. Generally neutral ointment bases are preferred. e. Freedom from Irritant Effect: Ointment bases used should be free from irritant effect on the skin. All bases used should be of high standard of purity and bases used specially for eye ointments should be non-irritating and free from foreign particles. f. Emollient Properties: Dryness and brittleness of the skin causes discomfort to the skin therefore the bases used should possess emollient properties that they should be able to keep the skin moist. For this purpose water and humectants such as glycerin and propylene glycol are used. Ointments containing wool fat, lard and liquid paraffin also act as emollients by preventing rapid loss of moisture from the skin. g. Ease of Application and Removal: The ointment bases used should be easily applicable as well as easily removable from the skin. Stiff and sticky ointments are not suitable as they may cause damage to the newly formed tissues of the skin. Therefore emulsion bases are more preferred as they are softer and spread more readily over the area to which they are applied. They can be easily removed by simply washing with water. 2. Pharmaceutical Factors a. Stability: Fats and oils obtained from animal and vegetable sources are liable to undergo oxidation unless they are suitably preserved. Lard, an animal fat used to be a common ingredient of ointment) but it is rarely used now a days because it easily gets rancid. Soft paraffin, simple ointment and paraffin ointment are inert and stable. Liquid paraffin is also stable but on prolonged storage it gets oxidized therefore an antioxidant like tocopherol may be incorporated. Emulsions prepared with wool fat are liable to surface discolouration. O/W type emulsion bases provide a good medium for growth of microorganisms, therefore must be suitably preserved. b. Solvent Properties: Most of the medicaments used in the preparation of ointments are insoluble in the ointment bases therefore they are finely powdered and distributed uniformly throughout the base. Phenol, if dispersed in finely powdered state may cause blisters therefore it must be dispersed in a suitable base which should keep the phenol in solution form. Hence a base consisting of a mixture of hard paraffin, soft paraffins, bees wax and lard is used for this purpose. Similarly in the case of compound mercury ointment, olive oil is used to keep the camphor in solution form. c. Emulsifying Properties: Hydrocarbon bases can absorb only a small amount of aqueous substances whereas some animal fats can absorb an appreciable amount of water, e.g. wool fat can take up about 50% of water, and when mixed with other fats can take up several times its own weight of aqueous or hydroalcoholic liquids. Hence wool fat is included in the base for eye ointments. Emulsifying ointment, cetrimide emulsifying ointment and cetomacrogol emulsifying ointment are capable of absorbing considerable amount of water, forming oil in water creams. d. Consistency: The ointments produced should be of suitable consistency. They should neither be too hard nor too soft. They should withstand the climatic conditions. Thus in summer they should not become too soft and in winter not too hard to be difficult to remove from the container and spread on the skin.
  • 18. Shamiul Bashar 1st Batch B. Pharm, VU 18 Pharmaceutical Excipients Coating Agent Coating is a process by which an essentially dry, outer layer of coating material is applied to the surface of a dosage form and agents which are used in this coating process is called coating agents. Similar to taste masking technology, the first coatings were solutions of sucrose (12–20%). Once polymers were discovered and understood, they were applied in low concentrations (1–3%) using organic solvents. Current technology uses polymers manufactured as latex or pseudo-latex dispersions to avoid the use of organic solvents. Depending on the application, aesthetic or functional coating, the use levels can range from 2 to 20% of the weight of the material being coated. Types: Three types of coating agents are used pharmaceutically, 1. Film coating. 2. Sugar coating. 3. Compression coating. Function of coating agents: 1. To improve appearance: often where the core tablet is of poor colour or shows mottling. 2. Protection from environmental conditions: Some of the ingredients may not be stable in the presence of moisture, light, oxygen etc. The product stability can be improved by coating. 3. Taste masking: Mask the bitter or unpleasant taste. 4. Odour masking: Mask the unpleasant odour of active ingredients like vitamins, antibiotics etc. 5. Change in appearance: To impart colour for easy identification during manufacture, dispensing, in use by patient and brand image building. 6. Ease of swallowing Examples: Excipients, Carboxymethyl cellulose sodium (CMC), Carnauba Wax, Cellulose acetate, phthalate (CAP), Ethylcellulose, Gelatin, Hydroxypropyl cellulose (HPC), Hypromellose (HPMC), Maltodextrin, Methylcellulose, Starch, Sucrose, Zein. Sorbents Sorbents are materials that soak up oil from the water. Types and examples of sorbents: • Natural sorbents- peat moss, sawdust, feathers, and anything else natural that contains carbon. • Synthetic sorbents- polyethylene and nylon etc.. Functions of sorbents: Sorbent are used for tablet/capsule moisture-proofing by limited fluid sorbing (taking up of a liquid or a gas either by adsorption or by adsorption) in a dry state. Solvents/Co-Solvents Solvent: A solvent is a substance that can dissolve a solute (a chemically different liquid, solid or gas) resulting in solution. A solvent is usually a liquid but it can also be solid or a gas. A solvent never changes its state forming a solution. Ideal characteristics of solvent: 1. It should either dissolve or disperse the polymer system. 2. It should easily disperse other coating solution component into the solvent system.
  • 19. Shamiul Bashar 1st Batch B. Pharm, VU 19 Pharmaceutical Excipients 3. Small concentration of polymer (2-10%) should not result in an extremely viscous solution system (>300cps) creating processing problem. 4. It should be colorless, tasteless, odorless, in-expensive, non-toxic, inert and non-flammable. 5. It should have rapid drying rate. 6. It should have no environmental impact. Solvent classification: On the basis of the forces of interaction occurring in solvents, one may broadly classify solvents as one of three types: 1. Polar solvents: Those made up of strong dipolar molecules having hydrogen bonding are known as polar solvent. e.g., water or hydrogen peroxide. 2. Semi-polar solvents: Those also made up of strong dipolar molecules but that do not form hydrogen bonds are known as semi-polar solvent. e.g., acetone or pentyl alcohol. 3. Non-polar solvents: Those made up of molecules having a small or no dipolar characters are known as non-polar solvent. e.g., benzene, vegetable oil, or mineral oil. Normally solvation of a solvent depends upon its classification. Generally polar solvent dissolves polar compound best and non polar solvent dissolves non polar compound best. Example and uses of solvent • The first choice for a solvent is water in which a drug is freely soluble. • Water –miscible solvent such as Chlordiazepoxide hydrochloride can be used to improve solubility and stability. • Oils are used as emulsion, intramuscular injections and liquid fill oral preparation. • Aqueous methanol is widely used in HPLC and is the standard solvent in sample extraction. • Other acceptable non-aqueous solvents are glycerol, propylene glycol, ethanol and are used generally for a lipophilic drug. Water is the solvent most widely used as a vehicle due to:  Lack of toxicity, physiological compatibility, and good solubilising power (high dielectric constant), but  Likely to cause instability of hydrolytically unstable drugs  Good vehicle for microbial growth Co-solvent: Co-solvents are defined as water-miscible organic solvents that are used in liquid drug formulations to increase the solubility of poorly water soluble substances or to enhance the chemical stability of a drug. Properties of co-solvent • Co-solvent increases the solubility of a drug. • An ideal co-solvent should possess values of dielectric constant between 25 and 80. • The most widely used system that will cover this range is a water/ethanol blend. • It should not cause toxicity or irritancy when administrated for oral or parental use • Other co-solvents are sorbitol, glycerol, propylene glycol and syrup. Application of co-solvent:  Water-miscible co-solvents are used to:  Enhance solubility, taste, anti-microbial effectiveness or stability  Reduce dose volume (e.g. oral, injections)  Or, conversely, optimise insolubility (if taste of API is an issue)  Examples: propylene glycol, glycerol, ethanol, low molecular weight PEGs  Water-immiscible co-solvents, e.g.  Emulsions / microemulsions using fractionated coconut oils
  • 20. Shamiul Bashar 1st Batch B. Pharm, VU 20 Pharmaceutical Excipients Chelating agent Chelating agents are molecules that are capable of forming complexes with the drug involving more than one bond it’s a complex compound contains one or more ring in its structure . Complexing agents also called “sequestrants” are substances which form chemical complexes with metallic ions. Sequestrants are used to stabilize fats and oils which undergo rancidity and reversion in the presence of the metals copper and iron. By chelating (sequestering) metals, oxidation is slow or entirely prevented. Calcium-Dinatrium-EDTA E385 is the most used one. e.g., ethylene diamine is bidentate and ethylene diamine tetraacetic acid is hexadentate. Example and uses of chelating agent: • EDTA: ethylene diamine tetraacetate is used for the estimation of metals ions. • EDTAH4: ethylene diamin tetraacetic acid is used for softening water. • Calcium Disodium Edetate: it is used in the treatment of heavy metal poisoning mostly caused by lead. • Disodium Edetate: it is used in hypercalcemic states. It is also useful in the treatment of cardiac arrhythmias. Buffering agent These are materials which, when dissolved in solvent will enable the solution to resist any change in pH should an acid or an alkali be added. The choice of suitable buffer depends on the pH and buffering capacity required. Change in the pH of preparation may occur during storage because of degradative reaction in the product. Interaction of the product with container component and dissolution or loss of gases vapours. So, buffers are used to maintain a required pH of the formulation in order to: • Ensure physiological compatibility • Maintaining/optimising chemical stability • Maintaining/optimising anti-microbial effectiveness • Optimise solubility (or insolubility if taste is an issue) The principle buffer systems employed for parenteral preparation are acetate, citrate and phosphate. Buffer system with concentration: Name of buffer System Concentration Acetate CH3COOH + CH3COONa 1-2% Citrate Citric acid + Na-citrate 1-3% Phosphate H3PO4 + Hs salt 0.8-2% Carbonate H2CO3 + NaHCO3 1-2% Features of buffering agent: • It should have a low toxicity. • It should be buffered at the range of 7.4 as the pH of the body is 7.4. • It should be non-irritant. Examples of buffering agent: Most of the buffering system are based on carbonate, citrates, gluconates , lactates, phosphates, or tartrates etc.
  • 21. Shamiul Bashar 1st Batch B. Pharm, VU 21 Pharmaceutical Excipients Surfactants Surfactants are compounds that lower the surface tension (or interfacial tension) between two liquids or between a liquid and a solid and increase the solubility. They are also known as surface active agents. They may be used as emulsifying agents, detergents, solubilising agents, wetting agents, foaming agents. antifoarning agents, flocculating agents and deflocculating agents. Properties of surfactants: A surfactant must fulfill two structural requirements- a) A surfactant must contain a lipophilic region. b) A surfactant must contain a hydrophilic region. In a surfactant both hydrophilic and lipophilic region must be balanced because then both the regions will be concentrated at an interface and therefore surface tension will be lowered. Types of surfactants: There are of four types of surfactants based on the charge of the hydrophilic region: 1. Anionic surfactant ( here the hydrophilic region is negatively charged i.e. an anion) Sodium lauryl sulphate - It is used as an excipient on some dissolvable aspirins and other fiber therapy caplets. 2. Cationic surfactant (here hydrophilic region is positively charged i.e. a cation) Cetyl trimethyl ammonium bromide (cetrimide) - is an effective antiseptic agent against bacteria and fungi. 3. Non-ionic surfactants : Tween 80 ( polyoxyethylene sorbitol monooleate)- Polysorbate 80 is an excipient that is used to stabilize aqueous formulations of medications for parenteral administration Span (sorbitan ester of lauric acid) 4. Amphoteric surfactant : Lecithin- it acts as a wetting, stabilizing agent and a choline enrichment carrier, helps in emulsifications and encapsulation, and is a good dispersing agent. N-dodecyl alanine. Q. Write down the mechanism action of surfactant. The molecules of a surfactant consist of two parts, i.e. a polar part and non-polar part. When such molecules are placed in two phases of different polarities the polar part moves towards high polarity phase while non-polar part moves towards the low polarity phase and phase and preferentially they are absorbed at the interphase. As the concentration is increased a level is reached where the interphase becomes saturated with surface active agent and no more space is available at the surface to be occupied. Therefore the surfactant molecules move towards the bulk of the solution. At this concentration an unusual phenomenon occurs. The molecules tend to form colloidal aggregates known as micelles consisting of 50 to 150 molecules of surface active agents. The concentration of surfactant at which the micelles are formed is known as critical micelle concentration or C.M.C. The solubilization begins at C.M.C and generally increases with increase the concentration of micelles. Q. Define micelle and CMC. Micelle: The colloidal aggregate molecules consisting of 50 to 150 molecules of surface active agents known as micelles. C.M.C: The concentration of surfactant at which the micelles are formed is known as critical micelle concentration or C.M.C.
  • 22. Shamiul Bashar 1st Batch B. Pharm, VU 22 Pharmaceutical Excipients Q. Elucidate the choice of emulsifying agents. To get an emulsion of required properties, the emulsifying agent selected must have the following qualities. 1. It should be capable of reducing the interfacial tension between the two immiscible liquids. 2. It should be capable of keeping the globules of dispersed liquid distributed indefinitely throughout the dispersion medium. 3. It should be non-toxic, 4. The odour and taste should be compatible with the preparation. 5. It should be chemically compatible with other ingredients of the preparation. 6. It should be able to produce and maintain the required consistency of the preparation. Viscosity imparting agents Viscosity imparting agents: These agents are used when it is desirable to increase or decrease the viscosity of a liquid either to serve as adjacent for palatability or to improve pour ability. They are also called thickening agents. Some viscosifiers go into solution, such as certain cellulose based polymers, resulting in a Newtonian- type viscosity. Other materials increase viscosity, while imparting a yield stress to the suspension. This type of product is known as thixotrope. Viscosity imparting agents are of two types: 1. Viscosity modifier-Viscosity modifiers decrease the viscosity of a liquid to improve pour ability and make it more palatable. 2. Viscosity enhancer- Viscosity enhancers increase the viscosity of a liquid to improve pour ability and make it more palatable. Most commonly used viscosity imparting agents are: Acacia, Agar, Sodium alginate, Bentonite, Carbomer, Carboxymethyl cellulose sodium (CMC), Guar gum, Hydroxypropyl cellulose (HPC), Hypromellose (HPMC), Methylcellulose, Pectin, Hydroxyethylcellulose, Polyvinyl alcohol (PVA), Polyvinylpyrrolidone (PVP) Humectant Humectant is a group of hygroscopic substances used to keep things moist. It is the opposite of a desiccant. They are used in many products including food, cosmetics, medicines and pesticides. Function: Their function is to retard evaporation of aqueous vehicle of dosage form- • To prevent drying of the product after application to the skin • To prevent drying of product from the container after first opening • To prevent cap-locking caused by condensation onto neck of container closure of a container after first opening N.B: Cap-locking involves liquid products that recrystallized at the bottle-cap interface and makes opening the bottle difficult after prolonged periods of non-use. These materials are hygroscopic and should be stored in well closed containers prior to use. Typical features of humectant: An ideal humectant should have the following criteria- 1. It must absorb moisture from atmosphere and retain the same under the normal conditions of atmospheric humidity. 2. It should be colorless or not of too intense color.
  • 23. Shamiul Bashar 1st Batch B. Pharm, VU 23 Pharmaceutical Excipients 3. It should have good odor and taste. 4. It should be nontoxic and nonirritant. 5. It should be noncorrosive to packaging materials 6. It should not solidify under normal conditions. 7. It should not be too costly. Classification of humectants with examples: There are three types of humectants such as inorganic humectants, metal organic humectants and organic humectants. 1. Inorganic humectants: These are limited used in cosmetics. Calcium chloride is an example. It has compatibility problems and corrosive in nature. Hence it is not frequently used in cosmetics. 2. Metal organic humectants: These are limited used in cosmetics because of compatibility problems, corrosive nature and pronounced taste. The example of this class is sodium lactate. 3. Organic humectants: These are widely used in cosmetics. They include polyhydric alcohols, their esters and ethers. The most commonly used organic humectants are glycerol, ethylene glycol, polyethylene glycol (PEG), diethylene glycol, tri ethylene glycol, propylene glycol, dipropylene glycol, glycerin, sorbitol, mannitol, glucose. Mode of action: • A humectant attracts and retains the moisture in the nearby air via absorption, drawing the water vapor into and/or beneath the organism/object's surface. • By contrast, desiccants also attract ambient moisture, but adsorbs -- not absorbs -- it, by condensing the water vapor onto the surface, as a layer of film. • Humectants absorb water vapors from atmosphere till a certain degree of dilution is attained. Aqueous solutions of humectants can reduce the rate of loss of moisture. Wetting Agents To aid ‘wetting’ and dispersion of a hydrophobic API, preservative or antioxidant  Reduce interfacial tension between solid and liquid during manufacture or reconstitution of a suspension  Not all are suitable for oral administration Examples include:  Surface active agents, e.g. • Oral: polysorbates (Tweens), sorbitan esters (Spans) • Parenteral: polysorbates, poloxamers, lecithin • External: sodium lauryl sulphate But these can cause excessive foaming (see anti-foaming agents) and can lead to deflocculation and undesirable physical instability (sedimentation) if levels too high  Hydrophilic colloids that coat hydrophobic particles, e.g. bentonite, tragacanth, alginates, cellulose derivatives. Also used as suspending agents, these can encourage deflocculation if levels are too low.
  • 24. Shamiul Bashar 1st Batch B. Pharm, VU 24 Pharmaceutical Excipients Anti-Foaming Agent Q. Define anti-foaming agent with examples. Anti-foaming: A defoamer or an anti-foaming agent is a chemical additive that reduces and hinders the formation of foam in industrial process liquids by reducing interfacial tension between two phases. Example: Insoluble oils. polydimethylsiloxanes and other silicones, certain alcohols, stearates and glycols, Simethicone (polydimethylsiloxane-silicon dioxide). Q. Why anti-foaming agents are used in industrial process? In industrial processes, foams pose serious problems. They cause defects on surface coatings. They prevent the efficient filling of containers. So, anti-foaming agents are used in industrial process to prevent formation of foams. Q. Write down the properties of an anti-foaming agent. Properties of an anti-foaming agent: 1. It should be insoluble in the foaming medium. 2. It should be surface active. 3. Should have low viscosity. 4. It should spread rapidly on foamy surfaces. 5. It has affinity to the air-liquid surface where it destabilizes the foam lamellas. Q. Write down the classification of anti-foaming agents. Classification of anti-foaming agents: Anti-foaming agents are classified into the following types. 1. Oil based anti-foaming agents: Oil based anti-foaming agents have an oil carrier. The oil might be mineral oil, vegetable oil, white oil or any other oil that is insoluble in the foaming medium except silicone oil. An oil based defoamer also contains a wax and/or hydrophobic silica to boost the performance. Typical waxes are ethylene bis stearamide (EBS), paraffin waxes, ester waxes and fatty alcohol waxes. These products might also have surfactants to improve emulsification and spreading in the foaming medium. 2. Powder anti-foaming agents: Powder anti-foaming agents are in principle oil based defoamers on a particulate carrier like silica. These are added to powdered products like cement, plaster and detergents. 3. Water based anti-foaming agents: Water based anti-foaming agents are different types of oils and waxes dispersed in a water base. The oils are often white oils or vegetable oils and the waxes are long chain fatty alcohol, fatty acid soaps or esters. These are normally best as deaerator, which means they are best at releasing entrained air. 4. Silicone based anti-foaming agents: Silicone-based anti-foaming agents are polymers with silicon backbones. These might be delivered as oil or a water based emulsion. The silicone compound consists of hydrophobic silica dispersed in silicone oil. Emulsifiers are added to ensure that the silicone spreads fast and well in the foaming medium. The silicone compound might also contain silicone glycols and other modified silicone fluids. Q. Write down the applications of anti-foaming agents. Applications of anti-foaming agents: 1. Detergents: Anti-foams are added in certain types of detergents to reduce foaming that might decrease the action of the detergent. For example dishwasher detergents have to be low foaming for the dishwasher to work properly.
  • 25. Shamiul Bashar 1st Batch B. Pharm, VU 25 Pharmaceutical Excipients 2. Food: When used as an ingredient in food, antifoaming agents are intended to curb effusion or effervescence in preparation or serving. The agents are included in a variety of foods such as chicken nuggets in the form of polydimethylsiloxane (a type of silicone). Silicone oil is also added to cooking oil to prevent foaming in deep-frying. 3. Industrial use: Defoamers are used in many industrial processes and products: wood pulp, paper, paint, industrial wastewater treatment, food processing, oil drilling, machine tool industry, oils cutting tools, hydraulics etc. 4. Pharmaceuticals: Antifoaming agents are also sold commercially to relieve bloating. A familiar example is the drug Simethicone, which is the active ingredient in drugs such as Entacyd plus. Plasticizer Q. Define plasticizer. Why plasticizer needed for film coating? Plasticizer: Plasticizers lower the glass transition temperature of polymers, specifically polymers used for coatings. By lowering the glass transition temperature, the polymers can partially melt, and the droplets can coalesce to form a completely sealed coating on a tablet or spheroid at a lower temperature, thus, preventing the active from being exposed to elevated processing temperatures. This affords better, more consistent release of the active. e.g., Commonly used plasticizers are Glycerin, Propylene Glycol, Triacetin, Triethanolamine, castor oil, PG, Glycerin, lower molecular weight (200- 400 series), PEG, surfactants etc. For aqueous coating PEG and PG are more used while castor oil and spans me primarily used for organic-solvent based coating solution. External plasticizer should he soluble in the solvent system used for dissolving the film former and plasticizer. Recommended levels of plasticizers range from 1-50% by weight of the film former. Plasticizers are normally used at concentration between 15-35% based on polymer weight. . Plasticizer need for film coating because 1. Plasticizers are low molecular weight organic solvents with high boiling points. They are used to alter the physical properties of a polymer (i.e. hard or brittle) and render it more flexible and softer to function as a film-coating material. 2. Plasticizers also have a significant influence on mechanical properties of the film. 3. Specifically, they can reduce cohesive intermolecular forces along the polymer chains and enhance flexibility by increasing strain or film elongation and decreasing tensile strength and elastic modulus of the polymer. 4. Additionally, they influence the permeability characteristics of the film, especially to water vapor, as well as lowering the glass transition temperature of the polymer to allow a more feasible coaling process. 5. Plasticizers also possess solvent power to insure compatibility with the polymer. 6. Plasticization time (i.e. mixing time of plasticizer with polymer) and plasticizer level influence the nature of the polymer films. Q. Classify plasticizer. Types of plasticizers: Three types of plasticizers are commonly used in pharmaceutical coating processes: a. Polyols: Water miscible 1. Glycerol (glycerin) 2. Propylene glycol (PG) 3. Polyethylene glycol (PEG 200-6000 grades)
  • 26. Shamiul Bashar 1st Batch B. Pharm, VU 26 Pharmaceutical Excipients b. Organic esters: 1. Diethyl phthalate (DEP) – water insoluble 2. Dibutyl phthalate (DBP) - water insoluble 3. Dibutyl sebacate (DBS) – water insoluble 4. Triethyl citrate (TEC) - water miscible 5. Acetyltriethyl citrate ( ATEC) - water insoluble c. Oils/glycerides: water insoluble 1. Castor oil 2. Distilled acetylated monoglycerides 3. Fractionated coconut oil Tonicity contributors Q. What do you mean by tonicity contributors? Give example with used concentration. Tonicity contributors: Tonicity contributors are the substances which are often included in parenteral product particularly in large volume preparation to make it isotonic with blood or other body fluid. Commonly used tonicity contributor Name Concentration Name Concentration 1. NaCl 0.9% 2. Lactose 5.0% 3. Dextrose 5.5% 4. Glycerine 2.25% 5. Mannitol 2.5% Q. Why tonicity contributors are used in pharmaceutical formulation? The compound which are used as tonicity contributors, reduce the pain at the site of injection. Adjustment of tonicity to isotonic condition is important, inorder to prevent the integrity of RBC by the addition of NaCl, Borax etc. Q. Define hypertonic, hypotonic and isotonic solution. Isotonic solution: The solutions that have same osmolarity to the blood or other body fluid are known as isotonic solution. i.e. 0.9% solution of sodium chloride is isotonic with plasma. Hypotonic solution: The solutions that have low osmolarity than the blood or other body fluid are known as hypotonic solution. i.e. 0.45% solution of sodium chloride hypotonic with plasma. Hypertonic solution: The solutions that have high osmolarity than the blood or other body fluid are known as hypertonic solution. i.e. 5% solution of sodium chloride hypertonic with plasma. Q. Problem with hypertonic and hypotonic solution in human body. The solutions which are not isotonic with plasma may be harmful to use. On injecting the hypotonic solutions into blood stream. It may enter the red blood cells in an attempt to produce equilibrium. The cells swell rapidly until they burst leading to haemolysis. As this damage is irreversible it may lead to serious danger to red blood cells. When hypertonic solution is injected into the blood stream, the water comes out of the membrane of red blood cells in order to reach equilibrium. The cells shrink leading to crenulation which is only a temporary damage. When the osmotic pressure of two solutions becomes equal the damaged cells will come to their original position. Hence hypertonic solutions may therefore be administered without permanent damage to the blood cells. They should be injected slowly to ensure rapid dilution into the blood stream and to minimize the crenulation of blood cells
  • 27. Shamiul Bashar 1st Batch B. Pharm, VU 27 Pharmaceutical Excipients Q. Write down the general principle for adjustment to tonicity and problems. General principle for adjustment to tonicity: Calculations for solutions iso-osmotic with blood and tear: There are generally two methods for adjustment of tonicity. These ares- 1. Based on freezing-point data. 2. Based on molecular concentration. 1. Based on freezing-point data: 0.52 − 𝑎 𝑏 Where, a = Freezing-point of unadjusted solution. b = Freezing-point of a 1% w/v solution of the adjusting substance. 2. Based on molecular concentration: i. For non-ionising solute 𝑊 = 0.3𝑀 ii. For ionising solute 𝑊 = 0.3𝑀 𝑁 Where, W = Concentration required in g per liter. M = Molecular weight of the N = Number of ion produce from each molecule of the solute assuming that dissociation is completed Problem 1: What concentration of Procain Hydrochloride will yield a solution iso-osmotic with blood plasma? Ans: Freezing point of 1% w/v solution of Procain Hydrochloride is -0.122°C ∴ Precentage w v⁄ of Procain Hydrochloride required = 0.52 − 0.00 0.122 = 4.26% w v⁄ Problem 2: Find the concentration of sodium chloride required to prepare a 1% solution of Cocaine Hydrochloride iso-osmotic with blood plasma. Ans: Freezing point of a 1% w/v solution of Cocaine Hydrochloride is -0.09°C and that of 1% w/v solution of sodium chloride is -0.576°C. ∴ Precentage w v⁄ of sodium chloride required = 0.52 − 0.09 0.576 = 0.746% w v⁄ Problem 3: Find the concentration of sodium chloride required to render a 1.5% solution of Procaine Hydrochloride iso-osmotic with blood plasma. Ans: Freezing point of a 1% w/v solution of procaine Hydrochloride is -0.122°C and that of 1% w/v solution of sodium chloride is -0.576°C. ∴ Precentage w v⁄ of sodium chloride required = 0.52 − (0.122 × 1.5) 0.576 = 0.585% w v⁄ Problem 4: Find the concentration of anhydrous dextrose needed to produce a solution iso- osmotic with blood plasma. Ans: The molecular weight of dextrose is 180 and it is non-ionising. ∴ 0.3 × 180 = 54 g per litre is required (The B. P. uses 5%) Problem 5: Find the concentration of boric acid required to produce a solution iso-osmotic with lachrymal secretion. Ans: The molecular weight of boric acid is 62 and it is a partially non-ionising. ∴ 0.3 × 62 = 18.6 g per litre (1.86% w v)⁄
  • 28. Shamiul Bashar 1st Batch B. Pharm, VU 28 Pharmaceutical Excipients Formula Nomenclature CCl3F CFC-11 CCl2F2 CFC-12 C2Cl2F4 CFC-114 Problem 6: Find the concentration of sodium chloride required to produce a solution iso-osmotic with blood plasma. Ans: The molecular weight of sodium chloride is 58.8 and it dissociates into 2 ions. ∴ 0.3 × 58.5 2 = 8.8 g per litre (0.88% w v)⁄ (The B. P. uses 0.90%) Propellants Q. Define aerosol with its composition and give its purpose of use. Aerosol: An aerosol or pressurized package is defined as "a system that depends on the power of a compressed or liquefied gas to expel the contents from the container." Composition: 1. Product concentrates: i. Active ingredient. ii. Surface active agents. iii. Antioxidant. 2. Propellant. An examination of the aerosol dosage form reveals the following specific advantages over other dosage forms: 1. A dose can be removed without contamination of remaining material. Stability is enhanced for those substances adversely affected by oxygen and/or moisture. When sterility is an important factor, it can be maintained while a dose is being dispensed. 2. The medication can be delivered directly to the affected area in a desired form, such as spray, stream, quick-breaking foam, or stable foam. 3. Irritation produced by the mechanical application of topical medication is reduced or eliminated. Other advantages are ease and convenience of application and application of medication in a thin layer. Q. What do you mean by propellants and classify it. Propellant: Propellants are the substances which are used for aerosol preparation to exert/ create vapour pressure. i.e. 1. HFA: HFA-227, HFA-134a 2. CFC: CFC-11, CFC-12, CFC-114 3. Compressed gas: Nitrogen, argon. Classification of propellants: The propellants used in aerosol system may be classified into 1. Liquified gases: a. Fluorinated hydrocarbons b. Hydrocarbons 2. Compressed gases: a. Insoluble in water, i.e. nitrogen, argon, and b. Soluble in water, i.e. carbon dioxide, nitrous oxide. Q. Write down the nomenclature of CFC and HFA. CFCs and HFAs are numbered using a universal system. 1. The first digit is the number of carbon atoms minus 1 (omitted if zero). 2. The second is the number of hydrogen atoms plus 1. 3. The third is the number of fluorine atoms. Chlorine fills any remaining valencies, given the total number of atoms required to saturate the compound. If asymmetry is possible, this is designated by a letter. i.e.
  • 29. Shamiul Bashar 1st Batch B. Pharm, VU 29 Pharmaceutical Excipients Q. Briefly describe Raoult’s law of vapour pressure. Raoult's Law: The vapour pressure of a mixed system is equal to the sum of the mole fraction of each, component multiplied by its vapour pressure. P = Pa + Pb Where P is the total vapour pressure of the system and Pa and Pb are the partial vapour pressures of the components, a and b. Pa = 𝑥aPa 0 Pb = 𝑥bPb 0 Where xa and xb are the mole fractions and Pa 0 and Pb 0 are the vapour pressures of components a and b, respectively. Q. Why use of CFCs as propellant decreased day by day than HFAs. CFCs are friendly to ozone in the earth's stratosphere. The reaction of CFCs with the ozone in the earth's stratosphere, which absorbs ultraviolet radiation at 300 nm, and their contribution to global warming are major environmental concerns. CFCs pass to the stratosphere, where in the presence of UV they liberate chlorine, which reacts with ozone. The depletion of stratospheric ozone results in increased exposure to the UV-B part of the UV spectrum, resulting in a number of adverse effects, in particular an increased incidence of skin cancer. The Montreal Protocol of 1987 was a global ban on the production of the five worst ozone-depleting CFCs by the year 2000, This was amended in 1992, so that production of CFCs in developed countries was phased out by January 1996. In the European Union, all ozonedepleting CFCs were banned by the end of 1995. HFAs are friendly to ozone in the earth’s stratosphere and do not cause such complication like CFCs. This is the reason that the use of CFCs as propellant decreased day by day than HFAs. Desiccant Q. Define desiccant with examples. Desiccant: A desiccant is a hygroscopic substance that induces or sustains a state of dryness (desiccation) in its vicinity. Commonly encountered pre-packaged desiccants are solids that absorb water. Desiccants for specialized purposes may be in forms other than solid and may work through other principles, such as chemical bonding of water molecules. They are commonly encountered in foods to retain crispness. Industrially, desiccants are widely used to control the level of water in gas streams. The most common desiccant is silica, an otherwise inert, nontoxic, water-insoluble white solid. Tens of thousands of tons are produced annually for this purpose. Other desiccants include activated charcoal, calcium sulfate, calcium chloride, and molecular sieves (typically, zeolites).  Why silica is used as desiccant in pharmaceutical industry? Q. How can you measure the efficiency of a desiccant? Performance efficiency One measure of desiccant efficiency is the ratio (or precentage) of water storable in the desiccant relative to the mass of desiccant. Another measure is the residual relative humidity of the air or other fluid being dried. The performance of any desiccant varies with temperature and both relative humidity and absolute humidity. To some extent, desiccant performance can be precisely described, but most commonly, the final choice of which desiccant best suits a given situation, how much of it to use and in what form, is made based on testing and practical experience.
  • 30. Shamiul Bashar 1st Batch B. Pharm, VU 30 Pharmaceutical Excipients Q. Write down the applications of desiccant. Applications of desiccant: 1. It is used in the manufacture of insulated windows where zeolite spheroids fil a rectangular spacer tube at the perimeter of the panes of glass. The desiccant helps to prevent the condensation of moisture between the panes. Another use of zeolites is in the dryer component of air conditioning systems to help maintain the efficacy of the refrigerant. Desiccants are also commonly used to protect goods in shipping containers against moisture damage. Hygroscopic cargo, such as cocoa, coffee and various nuts and grains are particularly susceptible to mold and rot when exposed to condensation and humidity. Because of this, shippers often take precautionary measures to protect against cargo loss. 2. Desiccants induce dryness in any environment and reduce the amount of moisture present in air. Desiccants come in various forms and have found widespread use in the food, pharmaceuticals, packing, electronics and many manufacturing industries. 3. Drying of solvents: Toluene is refluxed with sodium and benzophenone to produce dry, oxygen free toluene. The toluene is dry and oxygen free when the intense blue coloration from the benzophenone ketyl radical is observed. 4. Desiccants are also used to remove water from solvent typically required by chemical reactions that do not tolerate water, e.g., the Grignard reaction. The method generally, though not always. involves mixing the solvent with the solid desiccant. The dried solvent is then separated by the desiccant by filtration or distillation. Acidifying agents Acidifying agents will lower the pH of the solution. They are typically derived from phosphoric acid or blends of phosphate ester anionic surfactants containing free phosphoric acid. Their primary use is with insecticides when there is a need to prevent alkaline hydrolysis by lowering pH of the spray solution Urinary Acidifying Agents 1. Citric acid 2. Magnesium carbonate 3. Potassium acid phosphate 4. Renacidin Alkalinizing agent Alkalinizing agents are drugs used to manage disorders associated with low pH. For example, they may be used to treat acidosis due to renal failure. Used for oral or parenteral therapy, sodium bicarbonate is the commonly preferred alkalinizing agent. Others include potassium citrate, calcium carbonate, sodium lactate and calcium acetate. Alklinizing agent excipients are important in pharmaceutical formulations where the active pharmaceutical ingredient requires an alkaline environment for stability or therapeutic effectiveness.  Sodium bicarbonate  Sodium citrate/citric acid  Sodium lactate  Ammonia Solution  Ammonium Carbonate Alkaline agents are used to balance the acids of our body and to strengthen the effect of cleaning solutions. Maintaining a proper potential hydrogen (pH) level is vital to our health, keeping cholesterol, blood sugar and the heart's circular system running smoothly. If pH level is kept at 7, the alkaline and acids are equally balanced, influencing bone health, proper digestion, electrolyte activity and keeping immunity strong to prevent sickness.
  • 31. Shamiul Bashar 1st Batch B. Pharm, VU 31 Pharmaceutical Excipients Air Displacement Agents Air displacement agents: Substances employed to displace air in a hermetically sealed container to enhance product stability. (e.g. nitrogen. carbon dioxide). Anticaking agent An anticaking agent is an additive placed in powder or granulated materials, such as table salt, to prevent the formation of lumps and for easing packaging, transport and consumption. An anticaking agent in salt is denoted in the ingredients, for example, as "anti-caking agent (554)", which is sodium aluminosilicate, a man-made product. This product is present in many commercial table salts as well as dried milk, egg mixes, sugar products and flours. In Europe, sodium ferrocyanide (535) and potassium ferrocyanide (536) are more common anticaking agents in table salt. Natural anticaking agents used in more expensive table salt include calcium carbonate and magnesium carbonate. Some anticaking agents are soluble in water; others are soluble in alcohols or other organic solvents. They function either by absorbing excess moisture or by coating particles and making them water repellent. Calcium silicate (CaSiO3) a commonly used anti-caking agent, added to e.g. table salt, absorbs both water and oil. Anticaking agents are also used in non-food items such as road salt, fertilizers, cosmetics, synthetic detergents and in manufacturing applications. List of anticakiug agents: The following anticaking agents are listed in order by their E number.  E341 tricalcium phosphate  E460(ii) powdered cellulose  E470b magnesium stearate  E500 sodium bicarbonate  E535 sodium ferrocyanide  E536 potassium ferrocyanide  E538 calcium ferrocyanide  E542 bone phosphate  E550 sodium silicate  E551 silicon dioxide  E552 calcium silicate  E553a magnesium trisilicate  E553b talcum powder  E554 sodium aluminosilicate  E555 potassium aluminium silicate  E556 calcium aluminosilicnte  E558 bentonite  E559 aluminium silicate  E570 stearic acid  E900 polydimethylsiloxane Water repellent OWR (durable water repellent) is a coating added to fabrics at the factory to make them water- resistant (or hydrophobic). Most factory-applied treatments are fluoropolymer based. Durable water repellents are commonly used in conjunction with waterproof breathable fabrics such as Gore-Tex to prevent the outer layer of fabric from becoming saturated with water. This saturation called 'wetting out,' can reduce the garment's breathabilitv (moisture transport through the breathable membrane) and
  • 32. Shamiul Bashar 1st Batch B. Pharm, VU 32 Pharmaceutical Excipients let water through. As the DWR wears off over time, re-treatment is recommended when necessary. Many spray-on and wash-in products for treatment of non-waterproof garments and re-treatment of proofed garments losing their water-repellency are available from sources of sporting apparel. Sprays are made of Grangers, Nikwax, McNett, Trek7 and others. Older methods for factory application of DWR treatments involve applying a solution of a chemical onto the surface of the fabric by spraying or dipping. More recently the chemistry is applied in the vapor phase using Chemical Vapor Deposition (CVD) machinery. The advantages of CVD include: (1) It eliminates the use of hazardous and environmentally harmful solvents in the application process; (2) The process requires less chemical; (3) the waterproof layer is extremely thin and has less effect on the natural look and feel or the fabric. Later advances have eliminated perfluorinated acids considered to be potentially hazardous to human health by the US Environmental Protection Agency, from the application process. Q. How silicone water repellents work. Silicone water repellents or waterproofing agents generally come in two forms: 1. Elastomeric polydimethylsiloxanes - elastomeric coatings that adhere to the substrate and cure to form a flexible, protective membrane. 2. Penetrating water-repellent chemicals- reactive silanes and siloxane resins with crosslinkable side chains. These materials have smaller molecular structures which enable them to penetrate deeply into the substrate, where they chemically bond with it. Either of these materials can be delivered via solvent or aqueous emulsion. Q. Write a shot note on the following excipient. a. Acacia b. Tragacanth c. Lactose, Monohydrate and Microcrystalline Cellulose Sialagogues These materials are usually acidic, and their purpose in a formulation is to stimulate the production of saliva. They are mostly found in chewable products for children or in gum-based products. By facilitating the production of saliva, the masticated product is swallowed more readily, limiting the objectionable flavor of the active from lingering too long. Example: Citric acid, Fumaric acid, Tartaric acid
  • 33. Shamiul Bashar 1st Batch B. Pharm, VU 33 Pharmaceutical Excipients Excepient toxicity  Propylene Glycol Toxicity (Class: Solvent/ preservatives)  Propylene glycol (PG) is a general solvent with anti-microbial properties used in a wide range of pharmaceutical preparations including oral liquids, topicals and parenteral preparations  However, it’s use in large volumes in children is very much discouraged: • PG has been associated with cardiovascular, hepatic, respiratory and CNS adverse events, especially in neonates where the biological half-life is prolonged (~17h) compared with adults (5h). • I.V. parenterals containing PG must be infused slowly • PG also has a laxative action at high oral doses through high osmotic pressure effects.  Ethanol Toxicity (Class: Solvent)  Widely used as a co-solvent to aid solubility  In US, maximum permitted quantities in OTC products: • <0.5% for children under 6-years • <5% for children 6-12-years • <10% for children over 12-years  Acute (overdose) or chronic (long-term use) toxicity is possible  May cause adverse symptoms of intoxication, lethargy, stupor, coma, respiratory depression and cardiovascular collapse  Peanut Oil Toxicity (Class: Solvent)  Peanut oil is used as a food additive and as a solvent in intra-muscular injections  It has been suggested that the use of peanut oil in childhood (infant formula and topical preparations) can lead to later episodes of hypersensitivity, and therefore should be discontinued  Saccharin (Class: Sweetener)  Restricted regulatory acceptability  Poor aftertaste  Hypersensitivity reactions; mainly dermatologic  Paediatrics with allergy to sulphonamides should avoid saccharin  Aspartame Toxicity (Class: Sweetener)  Source of phenylalanine – possibly an issue for phenylketoneurics  Aspartame has been blamed for hyperactivity in children but as yet unproven  Sorbitol (Class: Sweetener)  Can induce diarrhea  Benzyl Alcohol toxicity in neonates (Class: Anti-microbial preservatives)  Widely used as a preservative in cosmetics, foods and pharmaceuticals (including injectables and oral liquids)  Toxic syndrome observed in neonates – it was attributed to the practice of “flushing out” umbilical catheters with solutions containing benzyl alcohol (BA), because of trace levels of benzaldehyde that were present  Dilution of nebulisation solutions with BA-preserved saline led to severe respiratory complications and even death in neonates. Attributed to accumulation of BA due to an immature metabolic capability.
  • 34. Shamiul Bashar 1st Batch B. Pharm, VU 34 Pharmaceutical Excipients  Sodium Benzoate toxicity (Class: Anti-microbial preservatives)  Widely used as a preservative in cosmetics, foods and pharmaceuticals (including injectables and oral liquids)  Injectable combinations of Na Benzoate and Caffeine should not be used in neonates; found to elicit non-immunological contact reactions, including urticaria and atopic dermatitis  Limitation on dosing of Na benzoate to neonates - ≤10mg/kg/day – due to immature metabolic capability  Thimerosal toxicity (Class: Anti-microbial preservatives)  Formerly widely used as a preservative in cosmetics, in soft contact lens solutions and pharmaceuticals (primarily vaccines)  Being phased out from most paediatric vaccines as better options emerge  Possible links with toxicity in paediatric vaccines, e.g. childhood autism, have been discounted after much debate  Lactose toxicity (immature metabolism) (Class: Diluents/ Filler)  Lactose occurs widely in dairy products and is used in infant feed formulae.  In pharmaceutical preparations it is widely used as a diluent in tablets and capsules, in lyophilised powders, as a sweetener in liquid formulations and as a carrier in dry powder inhalation products.  Lactose intolerance occurs when there is a deficiency in the intestinal enzyme lactase, leading to GIT build-up of lactose. There is then the risk of abdominal bloating and cramps.  Lactase is normally present at high levels at birth; declining rapidly in early childhood (4-8 years) Hypolactasia (malabsorption of lactose) can thus occur at an early age and, furthermore, this varies among different ethic groups.  Significant lactose intolerance can also occur in adults but this is rare.
  • 35. Shamiul Bashar 1st Batch B. Pharm, VU 35 Pharmaceutical Excipients Use of Different Excipients Sl. Excipient Use 1 Acacia Emulsifying agent; stabilizing agent; suspending agent; tablet binder; viscosity-increasing agent 2 Alginate Binder 3 Alginic Acid Stabilizing agent; suspending agent; tablet binder, tablet disintegrant; viscosity-increasing agent. 4 Aluminum Acetate Antiseptic 5 Benzyl Alcohol Antimicrobial preservative; disinfectant; solvent 6 Butyl Paraben Antimicrobial preservative 7 Butylated Hydroxy Toluene Antioxidant. 8 Citric acid Disintegrant 9 Calcium carbonate Tablet and capsule diluent; therapeutic agent 10 Candelilla wax Binder 11 Croscarmellose sodium Tablet and capsule disintegrant 12 Confectioner sugar Sugar coating adjunct; sweetening agent; tablet and capsule diluents 13 Colloidal silicone dioxide Adsorbent; anticaking agent; emulsion stabilizer; glidant; suspending agent; tablet disintegrant; thermal stabilizer; viscosity-increasing agent. 14 Cellulose Adsorbent; suspending agent; tablet and capsule diluent; tablet disintegrant.(cellulose microcrystaline) Adsorbent; glidant; suspending agent; tablet and capsule diluent; tablet disintegrant (cellulose powdered) Tablet and capsule diluent.(cellulose Silicified) 15 Plain or anhydrous calcium phosphate Diluent 16 Carnuba wax Binder 17 Corn starch Binder 18 Carboxymethylcellulose calcium Stabilizing agent; suspending agent; tablet and capsule disintegrant; viscosity-increasing agent; water-absorbing agent 19 Calcium stearate Tablet and capsule lubricant 20 Calcium disodium EDTA Chelation 21 Copolyvidone Film-former; granulating agent; tablet binder 22 Castor oil hydrogenated Extended release agent; stiffening agent; tablet and capsule lubricant 23 Calcium hydrogen phosphate dihydrate Diluent 24 Cetylpyridine chloride Antimicrobial preservative; antiseptic; cationic surfactant; disinfectant; solubilizing agent; wetting agent 25 Cysteine HCL Reducing Agent 26 Crosspovidone Tablet disintegrant. 27 calcium phosphate di or tri basic Tablet and capsule diluent Anticaking agent; buffer, nutrient; dietary supplement; glidant; tablet and capsule diluent and clouding agent( for calium phosphage tribasic)
  • 36. Shamiul Bashar 1st Batch B. Pharm, VU 36 Pharmaceutical Excipients Sl. Excipient Use 28 Dibasic Calcium Phosphate Diluent 29 Disodium hydrogen phosphate Buffering agent 30 Dimethicone Antifoaming agent;emollient 31 Erythrosine Sodium Color 32 Ethyl Cellulose Coating agent; flavoring fixative; tablet binder; tablet filler; viscosity-increasing agent. 33 Gelatin Coating agent; film-former; gelling agent; suspending agent; tablet binder; viscosity-increasing agent 34 Glyceryl monooleate Nonionic surfactant 35 Glycerin Antimicrobial preservative; emollient; humectant; plasticizer; solvent; sweetening agent; tonicity agent 36 Glycine Tonicity 37 Glyceryl monostearate Emollient; emulsifying agent; solubilizing agent; stabilizing agent; sustained-release ingredient; tablet and capsule lubricant 38 Glyceryl behenate Coating agent; tablet binder; tablet and capsule lubricant 39 Hydroxy propyl cellulose Coating agent; emulsifying agent; stabilizing agent; suspending agent; tablet binder; thickening agent; viscosity-increasing agent. 40 Hydroxyl propyl methyl cellulose Coating agent; film-former; rate-controlling polymer for sustained release; stabilizing agent; suspending agent; tablet binder; viscosity-increasing agent. 41 Hypromellose Coating agent; film-former; rate-controlling polymer for sustained release; stabilizing agent; suspending agent; tablet binder; viscosity-increasing agent. 42 HPMC Pthalate Coating agent. 43 Iron oxides or ferric oxide Color 44 Iron oxide yellow Color 45 Iron oxide red or ferric oxide Color 46 Lactose hydrous or anhydrous or monohydrate or spray dried Binding agent; diluent for dry-powder inhalers; lyophilization aid; tablet binder; tablet and capsule diluent.( lactose anhydrous) Binding agent; diluent for dry-powder inhalers; tablet binder; tablet and capsule diluent(lactose monhydrate) Binding agent; diluent for dry-powder inhalations; tablet and capsule diluent; tablet and capsule filler.(lactose spray dried) 47 Magnesium stearate Tablet and capsule lubricant 48 Microcrystalline cellulose Adsorbent; suspending agent; tablet and capsule diluent; tablet disintegrant same as cellulose see above it is just that mcc is usp 49 Mannitol Sweetening agent; tablet and capsule diluent; tonicity agent; vehicle (bulking agent) for lyophilized preparations 50 Methyl cellulose Coating agent; emulsifying agent; suspending agent; tablet and capsule disintegrant; tablet binder; viscosity- increasing agent 51 Magnesium carbonate Tablet and capsule diluent 52 Mineral oil Emollient; lubricant; oleaginous vehicle; solvent 53 Methacrylic acid copolymer Coating